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  2Abstract 
 
Gustafsson, A. 2004. Antibiotic associated diarrhea in horses, with special reference to 
Clostridium difficile. Doctor´s dissertation. 
ISSN 1401-6257, ISBN 91-576-6652-0 
 
Antibiotic associated diarrhea is a serious illness in horses with high mortality. Affected 
horses are often hospitalized, with the disease appearing after a few days of antibiotic 
treatment. Another risk group for developing this acute diarrhea appears to be healthy 
mares with foals under treatment with oral erythromycin and rifampicin for Rhodococcus 
equi pneumonia. In humans, C. difficile is the agent most often implicated in antibiotic 
associated diarrhea. When the present work was initiated this organism was not reported as 
a pathogen in adult horses. The aim of this thesis was to evaluate the impact of antibiotic 
treatment on the equine intestinal microflora with focus on the risk for development of 
antibiotic associated diarrhea and its connection to C. difficile.  
C. difficile and/or its cytotoxin was demonstrated in 40% of horses with acute colitis 
developing during antibiotic treatment but not found in other groups. All of these horses 
were treated with β-lactam antibiotics. The influence of different antibiotics was further 
evaluated in experimental studies. It was demonstrated that very low oral doses of 
erythromycin could induce acute colitis associated with C. difficile, thus, suggesting that the 
fatal colitis affecting the mares with foals under treatment for R. equi pneumonia was due to 
accidental ingestion of erythromycin. In contrast, very low oral doses of rifampicin and 
therapeutic doses of both oral and i.v. trimethoprim/sulfadiazine induced neither 
gastrointestinal disturbances nor major changes in the intestinal flora. In an oral infection 
model,  C. difficile was cultured from faecal samples on significantly more sampling 
occasions from horses pre-treated with penicillin than from untreated horses indicating that 
penicillin treatment can predispose to establishment of C. difficile in the horse intestine.  
This work demonstrates that antibiotic treatment is one of the most important risk factors 
for development of acute colitis in the horse. Antibiotics known to be associated with a high 
risk for development of colitis, such as erythromycin should be avoided. However even 
pencillin poses a risk. As C. difficile is associated with acute colitis in adult horses being 
treated with antibiotics, routine examination for C. difficile is recommended in cases of 
antibiotic associated diarrhea.  
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AAD     antibiotic  associated  diarrhea 
 
CdAD   Clostridium difficile associated diarrhea 
 
cfu      colony  forming  units 
 
CR      colonization  resistance 
 
CPE    Clostridium perfringens enterotoxin 
 
FAA     fastidious  anaerobe  agar 
 
HPLC      high pressure liquid chromatography 
 
MIC    minimum  inhibitory  concentration 
 
NSAID    non-steroidal  anti-inflammatory  drug 
 
PBS    phosphate  buffered  saline 
 
PCR    polymerase  chain  reaction 
 
PCV     packed  cell  volume 
 
TCCFA     taurocholate cycloserine cefoxitin and fructose agar 
 
TMP/SDZ   trimethoprim/sulfadiazine 
 
t1/2β    half-life of drug (h) 
 
VFA     volatile  fatty  acids 
 
WBC     white  blood  cells 
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Background for studies 
In the beginning of the 1990s, several equine clinics in Sweden and Norway 
experienced an increasing problem with horses while hospitalized, developing 
acute severe diarrhea (acute colitis) accompanied with high case fatality. Two 
groups of horses could be identified. The first group was adult horses being treated 
with antibiotics for reasons other than diarrhea. The second group appeared to be 
completely healthy mares whose foals were being treated for Rhodococcus equi 
(R. equi) pneumonia with erythromycin and rifampicin orally. At a meeting in 
1992 in Lillehammer, Norway, various clinics presented a summary of their cases. 
The result of those discussions was a collaborative project between the 
Departments of Antibiotics and Bacteriology, National Veterinary Institute and the 
Department of Large Animal Clinical Sciences, Faculty of Veterinary Medicine 
with the aim to further study possible causes for this diarrhea syndrome, of which 
the underlying cause was obscure. Clostridium difficile (C. difficile) was by then 
well known in relation to antibiotic associated diarrhea (AAD) in humans, but not 
recognised as a pathogen in adult horses. 
 
Acute colitis 
Definition, nomenclature and frequency 
In adult horses, apart from the transient diarrhea associated with dietary changes, 
acute severe diarrhea (acute colitis) is relatively uncommon. However, acute 
colitis attracts much attention as the disease occurs suddenly, invariably with no 
premonitory signs, and has high mortality despite intensive and expensive 
treatment. The incidence of colitis can be increased in certain management 
conditions, especially in stressful environments, such as is presented at racing 
stables or equine hospitals (Rooney, Bryans & Doll, 1963; Wierup, 1977; 
Madewell et al., 1995).  
 
Diarrhea in the adult horse rarely occurs without colonic dysfunction. The name 
colitis refers to inflammation of the large colon, and as the caecum is also often 
involved, typhlocolitis or even enterocolitis is also used interchangeably for 
colitis. Less affected sites of inflammation include the upper small intestine and 
the small colon. The syndrome and its severity was already described in the 19
th 
century in Veterinary Notes at the Ontario Veterinary College by Smith (1885), 
who wrote that ‘dysentery is an affection of the mucous membrane, especially of 
the large intestines.’ In a well-recognised key report of acute colitis in the horse 
by Rooney and co-authors (1963), the name ‘colitis X’ was proposed, referring to 
a peracute fatal disease with unknown aetiology. Showing little progress, even 
today an aetiology is frequently not determined (Palmer, 1992a; Murray, 1997), as 
also reflected by the name ‘idiopathic colitis’ (Prescott et al., 1988; Staempfli, 
Townsend & Prescott, 1991). However, as several different causes actually have 
been identified, the name acute colitis or enterocolitis is currently preferred. In 
Sweden the disease became known especially among horse owners as Baron Gruff 
  9 Disease. This name stems from a very talented four-year thoroughbred trotter 
named Baron Gruff, which died from the disease in 1969, and shortly thereafter 
several other trotters died with similar signs (Bergsten & Lannek, 1970). Notably, 
Baron Gruff became even more famous after his death. 
 
How often does this disease occur? In Table 1, data from some published studies 
are shown. Since principles of case selection differ greatly between studies their 
findings cannot be directly compared to each other. However, it is readily apparent 
that this is a worldwide problem with a high mortality. Shown in table 2 are the 
cases presented at the Norwegian-Swedish meeting in 1992, with the frequency of 
antibiotic treatment and general anaesthesia included. The cases presented there 
were remarkably similar and all of a severe nature. Of particular note was that the 
overwhelming majority of the horses had previously been given antibiotics, or 
were suspected to be exposed to accidental intake of antibiotics (mares with foals 
being treated orally with erythromycin and rifampicin), and that the mortality was 
very high (54-83%). 
 
Pathophysiologic mechanisms of colitis 
The pathophysiologic changes exhibited in acute colitis are very similar regardless 
of different aetiologies. The intestinal mucosa normally acts as a barrier between 
the intestinal content and the blood. This barrier is disrupted when the intestinal 
mucosa in damaged. There are various possible mechanisms for this damage. For 
infectious causes, there could be a primary infection with a pathogen solely 
responsible, or alternatively, changes in the composition of the intestinal flora that 
promote the growth of potentially pathogenic resident bacteria. The pathogens 
subsequently penetrate and invade the mucosa or produce cytotoxins that greatly 
alter the integrity of the mucosal surface (Roberts, 1990). Alternatively, as with 
any state of colic, especially those needing surgical treatment, impairment of 
intestinal oxygenation and motility can also cause mucosal devitalisation and 
disrupt this barrier. 
 
With colitis a number of types of inflammatory cells and mediators are activated 
resulting in local inflammation. There is a loss of mucosal epithelium and 
occurrence of inflammatory infiltrates of the mucosa and submucosa of colon, 
caecum and ileum, leading to increased permeability of mucosal and submucosal 
capillaries and oedema formation. As an attendant phenomenon to this breakdown 
of the mucosal barrier, the large endotoxin pool that is normally restricted to the 
intestinal lumen (King & Gerring, 1988) gains access to the blood stream. The 
horse appears to be extremely sensitive to the effects of endotoxin (Burrows, 
1981). Furthermore, the enteric nervous system is also intimately involved in fluid 
regulation. Normally, the adrenergic drive for absorption predominates over the 
cholinergic secretory drive. The inflammatory mediators of colitis also have an 
effect on these regulation mechanisms that can upset the normal balance. As a 
consequence, derangement of fluid, electrolyte and acid-base status occur, as well 
as toxemia (Roberts, 1990). 
 
  10Table 1. Recently published studies on diarrhea in adult horses 
 
Place  Nr of cases/time 
period 
Mortality (%)  Reference 
Southern England  66/2 yr  33  Mair et al., 1990 
Guelph  47/12 yr  43  Staempfli, Townsend & Prescott, 
1991 
Sydney 86/6  yr  28  Stewart  et al., 1995 
Oslo  13/4 yr  54  Larsen, Dolvik & Teige, 1996 
Sweden  39/4 yr  44  Study I, 1997 
Guelph 71/4  yr  30  Sutton  et al., 1998 
Edinburgh  16/3 yr  38  McGorum, Dixon & Smith, 1998 
Texas  122/7 yr  25  Cohen & Woods, 1999 
Guelph  40/2 yr  15  Weese, 2000 
 
 
 
 
 
 
 
 
Table 2. Diarrhea-cases in adult horses presented in Lillehammer 1992 
 
Place Nr  of  cases/time 
period 
Mortality (%)  Antibiotics  Anaesthesia 
Skara 17*/4  yr  65  nr**  nr** 
Bjerke 23/3  yr  56  16  18 
Oslo 13/4  yr  54  11  10 
Helsingborg 6/1  yr  83  6  3 
Umeå 1  100  1  1 
Uppsala 19*/3  yr  68  15  10 
 
* Including mares with foals treated for R. equi pneumonia with oral erythromycin and 
rifampicin, 10 cases in Skara and 4 cases in Uppsala. 
** nr = not recorded. 
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Vaughan stated in 1973 that the subsequently described syndrome ‘Colitis X’ is 
basically severe shock. The main signs were also floridly described as far back as 
300 years ago by our Swedish veterinary forefather Peter Hernquist. Manuscripts 
from the 18
th century describe the clinical course as follows; ‘dysenteria appears 
with fever, strong anguish, anorexia, strong thirst, cramps, colic and watery 
diarrhea’ (author’s translation from old Swedish) (Dyrendahl, 1996). Diarrheic 
horses with different causative agents show a common set of clinical signs induced 
by hypovolemia and endotoxemia. Physical examination reveals mainly 
nonspecific findings, but can provide some important information suggesting a 
cause. Above all, assessing the clinical signs gives an impression of disease 
severity and thereby helps to guide treatment. The description of the clinical 
picture is similarly well documented in various textbooks and review papers 
(Murray, 1992; Palmer, 1992a; Murray, 1997; Cohen & Divers, 1998a; Divers, 
2002).  
 
The clinical course of the disease ranges from peracute with sudden death to a 
more prolonged stadium with varying clinical signs. Initial signs to appear often 
include the triad of anorexia, fever and severe depression. Diarrhea can coincide, 
or follow soon after, and can be abruptly projectile and watery, to initially cowpat 
in consistency which slowly develops to looser faeces. Variable degrees and signs 
of colic often accompany colitis, especially at the onset of disease (Rooney, 
Bryans & Doll, 1963). Elevated heart rate, occasionally arrhythmias and murmurs, 
weak peripheral pulse, prolonged capillary refill time, injected or purple and often 
dry mucous membranes can all be observed. Breathing frequency is also often 
elevated. These cardiopulmonary abnormalities s are believed to result from pain, 
dehydration and endotoxemia. The intestinal sounds vary greatly from increased, 
high-pitched sounds to complete absence of sounds. In the opinion of Cohen & 
Divers (1998a) (and of the author), horses with colitis that have scant faeces, 
severe tympany and colic have a poor prognosis. After several days, ventral and 
limb oedema frequently appear, likely due to hypoproteinemia resulting from 
protein exudation through the inflamed intestine. If the disease continues for some 
days, these horses loose weight remarkably rapidly due to a combination of 
anorexia, malabsorption of volatile fatty acids (VFA), protein wasting, and a 
hypermetabolic state where metabolic alterations result from excessive production 
and release of inflammatory mediators. These processes lead to protein calory 
deficit, and catabolism of both plasma proteins and body tissues occurs. Clearly, 
there are great differences in the spectrum of clinical signs and alterations between 
cases of colitis, where one horse can exhibit severe endotoxemia and dehydration 
but with no diarrhea and another horse profuse watery diarrhea in the almost 
complete absence of signs of endotoxemia. 
 
Laboratory evaluation of horses with colitis most often includes assessment of 
white and red blood cell parameters, plasma protein fractions and fibrinogen, and 
serum electrolytes. The total white blood cells (WBC) and neutrophil counts 
initially decrease in most cases of acute colitis regardless of aetiology. The 
exception to this is larval cyathostomiasis, where neutrophilia without left shift is 
often observed (Giles, Urquhart & Longstaffe, 1985). The morphology of the 
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degree of endotoxemia and help predict improvement or deterioration (Murray, 
1997). Fibrinogen is often elevated with inflammation, whereas in selected severe 
peracute cases of endotoxemia with disseminated intravascular coagulation it can 
paradoxically be below normal values (Kirby & Rudloff, 2000). The packed cell 
volume (PCV) is elevated with dehydration and can be used as a rough guide for 
fluid therapy. However, it can also be elevated due to splenic contraction due to 
endotoxemia and pain. Normally, the total protein rises initially in horses with 
acute colitis but then subsequently decreases markedly as protein is lost though the 
inflamed intestine and also due to markedly increased protein catabolism over the 
following days of illness. Thus, to allow for an estimation of the degree of 
dehydration and protein loss it is necessary to also consider the hydration status 
clinically. Horses with diarrhea are also typically hyponatremic, hypochloremic 
and hypokalemic, due to excessive intestinal losses. Total calcium may also be 
low after some days of anorexia. Decreased renal function and leakage of liver 
associated enzymes may be detected on blood chemistry analysis, reflecting 
mainly hypoperfusion and endotoxemia. Diarrheic horses are also often acidotic, 
due to lactate elevation as a consequence of poor perfusion and intestinal loss of 
fluid relatively rich in sodium, potassium and bicarbonate ions. In a retrospective 
study of 47 horses with acute colitis by Staempfli, Townsend & Prescott (1991), 
base excess was the best predictor of death or survival, and was significantly more 
negative in the non-surviving category. 
 
Severe sequelae to colitis occur. Of these laminitis probably is the most common 
and can be a key reason for euthanasia months after discharge (Staempfli, 
Townsend & Prescott, 1991). The prevalence of laminitis following colitis has 
been reported to be between 11.5 - 30% (Staempfli, Townsend & Prescott, 1991; 
Stewart et al., 1995; Cohen & Woods, 1999). It is puzzling that laminitis is seldom 
seen as sequela to colitis in Sweden but is otherwise a common disease in this 
country. Sound disease statistics however are lacking, and need to be performed to 
substantiate this clinical impression. Other medical complications include acute 
coagulopathy, thrombophlebitis, acute renal failure, chronic diarrhea and gastric 
ulcers. 
 
Pathology 
Macroscopically acute colitis often is characterised by retention of dark, non-
clotting blood in the subcutaneous tissues and visceral organs, hyperaemia, 
petechiae or diffuse hemorrhages with marked congestion in the large intestine 
mucosa and muddy or watery, brown or dark red, foul-smelling content of large 
intestine. From the serosal surface the caecum and colon can have a cyanotic 
colour and frequently have oedema in the submucosa. Histologically all visceral 
organs are often congested with the most prominent changes in the large intestinal 
mucosa where fibrin thrombi are frequently noted. Furthermore, epithelial changes 
of the large intestinal mucosa range from exfoliation of the epithelial cells to 
hemorrhages, fibrinous exudation and neutrophilic infiltration (Rooney, Bryans & 
Doll, 1963; Umemura et al., 1982). 
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There are a number of both infectious and non-infectious causes of colitis in the 
horse. Of the infectious agents, C. difficile, Clostridium perfringens ( C. 
perfringens) and Salmonella spp. appear to be key contributors. In association 
with these organisms, or even in their apparent absence, colitis can also occur as 
an adverse consequence of antibiotic administration, so called ‘antibiotic 
associated diarrhea’. However, in a substantial number of cases an etiological 
diagnose is not made due to failure to demonstrate a causative agent. Careful 
review of signalement and history, including age and intended use, feeding, 
deworming schedule, recent or ongoing medications as well as duration and 
character of the signs can provide important information concerning the cause and 
prognosis, based on the epizootiology of various causes of equine colitis. 
Furthermore, several risk factors in addition to antibiotic treatment may contribute 
to the development of disease, such as treatment with NSAIDs, administration of 
anthelmintics, and/or occurrence of stressful events such as transportation and 
racing, hospitalization, surgical treatment, respiratory disease, feeding alterations, 
starvation and even other less well-defined stressful events (Rooney, Bryans & 
Doll, 1963; Larsen, 1997).  
 
Antibiotic associated diarrhea (AAD) 
Prior antibiotic treatment is considered by many authors to be the most important 
factor for development of acute colitis in the horse. The association of antibiotic 
treatment with diarrhea cases has been described to be between 22-28% (Cohen & 
Woods, 1999; Sutton et al., 1998; Weese, 2000). Antibiotic therapy in horses is 
associated with disruption of the intestinal microflora, which can occasionally 
result in acute potentially life-threatening colitis. Although a causative relationship 
is difficult to prove, a presumptive diagnosis can be made when there is a history 
of initiation or cessation of antibiotic treatment coupled with the onset of an 
otherwise unexplained diarrhea. The equine intestinal microflora consists of 
hundreds of different bacterial species of which more than 99% are anaerobic 
(Jones, 2000). With antibiotic treatment the normal intestinal flora is disrupted and 
the intricate balance between the different bacterial species needed for 
colonization resistance (CR) may be greatly altered (Vollaard & Clasener, 1994). 
Further, the disturbance can lead to abnormal VFA production and disruption of 
normal secretory and absorptive patterns in the colon, facilitating the proliferation 
of potential pathogens and their expression of toxins in the intestine (Larsen, 
1997; Murray, 1997). Even though the anaerobic flora is generally sensitive to 
many antibiotics, the degree of disturbance is, in part, dependent on the 
antibacterial spectrum of the drug. As well, the composition of the intestinal flora, 
in particular the presence of potential pathogens and their antibiotic susceptibility, 
may be key predisposing facets in the genesis of diarrhea. The pathogen most 
implicated in AAD is C. difficile, but C. perfringens, possibly other clostridia and 
Salmonella have also been associated with the syndrome. An additional factor in 
appearance of AAD can be nosocomial infection and selection of antimicrobial 
resistant bacterial strains in animal hospitals. 
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many other similarly treated animals remain unaffected are unclear. Of key 
importance is that the overall effect on the horse of the micro-floral disturbance 
may vary greatly according to feeding schedule, general health state, intestinal 
motility and secretion, tissue oxygenation, exercise, and especially various forms 
of stress (Larsen, 1997). The pathogenesis is likely complex and various factors 
probably have to exert their respective influences sequentially or simultaneously.  
 
Tetracyclines 
Different antibiotics have been associated with development of diarrhea, with the 
first documented being tetracycline. Severe diarrhea occurred in two of three 
horses after oxytetracycline was given i.v. in a single, excessive dose (27-40 
mg/kg) for studying its uptake in bone. The antibiotic was given 48-72 h prior to 
surgery. The authors reproduced a similar clinical picture in three of four 
experimental horses not subjected to the stress of general anaesthesia and surgery 
(Andersson et al., 1971). With a concurrent stress of general anaesthesia, Cook 
(1973) reported three cases of severe diarrhea after oxytetracycline administration 
at therapeutic doses (4 mg/kg). Together with a similar case with fatal outcome, 
Baker & Leyland (1973) described profuse diarrhea and death in four horses after 
oxytetracyline was given as a single prophylactic measure in doses of 1-2 mg/kg. 
Owen (1975) reported that three of eight horses receiving oxytetracycline 
developed diarrhea and shed Salmonella. Exposure of four horses to tetracycline-
contaminated sweet feed (analysis revealed a concentration of tetracycline of 10 
mg/kg feed) resulted in acute colitis and subsequent death in one horse and milder 
diarrhea in the others (Keir, Staempfli & Crawford, 1999). 
 
Macrolides / Lincosamides 
Following these reports involving tetracyclines, other antibiotics came to light in 
association with diarrhea, most strikingly macrolides/lincosamides. Raisbeck, Holt 
& Osweiler (1981) described lincomycin-associated colitis due to feed 
contamination. All seven horses receiving accidental doses of less than 0.5 mg/kg 
for two days were affected. Prescott et al. (1988) experimentally induced acute 
colitis in five of seven ponies (for two of the ponies in combination with oral 
administration of intestinal content from horses previously diseased from colitis) 
by oral administration of lincomycin at a dose of 25 mg/kg q12h for three to seven 
treatments. The same investigators induced colitis with a single oral dose of 
lincomycin (25 mg/kg) in all eight ponies studied (two of which were 
subsequently gavaged with a suspension of Clostridium cadaveris) (Staempfli, 
Prescott & Brash, 1992). Båverud et al. (1998) reported colitis in 11 mares with 
foals treated for R. equi pneumonia with oral erythromycin and rifampicin. An 
accidental intake of erythromycin from the foal treatment was suspected.  
 
Other antibiotics 
In addition to the above findings, the presumed ‘safer’ commonly used antibiotics 
such as trimethoprim / sulfonamides and β-lactams (penicillin, ampicillin, 
cephalosporins), and other less commonly used antibiotics have also more recently 
been connected with AAD in the horse. In a comparison of the side effects of oral 
  15 treatment with trimethoprim/sulphadiazine (TMP/SDZ) and pivampicillin 
involving 200 horses, there were significantly more horses with diarrhea and loose 
faeces in the TMP/SDZ treated group (Ensink et al., 1996). In one retrospective 
study the most commonly administered antimicrobial prior to development of 
diarrhea was a trimethoprim/sulphonamide combination (Cohen & Woods, 1999). 
Even more recently, oral treatment with ciprofloxacin was associated with 
development of acute colitis in four horses (Weese et al., 2002). Furthermore, 
there has been anecdotal association between ceftiofur and AAD, and a higher 
incidence of diarrhea after ceftiofur treatment in connection with general 
anaesthesia and surgery (Foreman, 1998). One horse developed acute diarrhea 
after experimental treatment with oral bacitracin for four days (Collinder et al., 
2000). In other studies of AAD the majority of horses had been given penicillin 
(Study I in this thesis; McGorum, Dixon & Smith, 1998; Weese, 2000).  
 
Which antibiotics are associated with higher risk? 
From the reports above, as in human medicine (Möllby; Nord & Aronsson, 1980; 
Aronsson, Möllby & Nord, 1982; Bartlett, 1990; Sullivan, Edlund & Nord, 2001), 
it can be concluded that most antibiotics are potentially able to disturb the 
intestinal microflora sufficiently to induce disease. However, the relative risk of 
developing AAD depends on which antibiotic is being administered and its route 
of administration. Traditionally, broad-spectrum antibiotics have been thought to 
be associated with a higher risk, both in horses and humans. However, according 
to current understanding in human medicine, antibiotics with a high activity 
against anaerobic bacteria are generally regarded to be of higher risk with respect 
to AAD, and more specifically Clostridium-associated diarrhea (Fekety et al., 
1979; McFarland, Surawicz & Stamm, 1990). This seems also to be applicable in 
horses. Anaerobic bacteria are usually susceptible to lincosamides, macrolides, β-
lactams and tetracyclines, which are the antibiotics mostly associated with acute 
colitis in horses. Antibiotics with less effect on anaerobic bacteria include 
trimethoprim/sulfonamides, fluoroquinolones and aminoglycosides, which are in 
the group of antibiotics presumed to be ‘safer’ with respect to AAD.  
 
Antibiotics for oral administration and parenterally administered antibiotics that 
undergo enterohepatic circulation or excretion into the gut lumen are more likely 
to reach significant concentrations in the large intestine and thereby cause severe 
disturbance of the intestinal microflora (Jones, 2000). Oxytetracycline, 
lincomycin, erythromycin, rifampicin, and some cephalosporins are antibiotics that 
are incompletely absorbed from the intestine or are excreted from the liver mainly 
in the active form (Prescott & Baggot, 1993; Beard, 1998). The increased hazard 
with most of these antibiotics has been documented (Andersson et al., 1971; 
Raisbeck, Holt & Osweiler, 1981, Prescott et al., 1988; Staempfli, Prescott & 
Brash, 1992). Furthermore, factors such as possible enzymatic inactivation of the 
antibiotic and binding to intestinal material are also of importance in the degree of 
exposure that the intestinal flora undergoes (McKellar & Horspool, 1995; van 
Duijkeren et al., 1995a). However, the ecological outcome of antibiotic therapy is 
also dependent on individual variations of pharmacokinetics and composition of 
the normal microflora.  
 
  16Clostridium difficile 
In humans, the pathogen most commonly implicated in AAD is C. difficile 
(Lyerly, Krivan & Wilkins, 1988; Kim et al., 1981; Tabaqchali & Jumaa, 1995, 
Thomas, Stevenson & Riley, 2003). This organism is a large Gram-positive rod 
that produces endospores and grows anaerobically. While C. difficile produces 
several hydrolytic enzymes and at least five toxins, but only enterotoxin A and 
cytotoxin B have been studied enough to confirm their role in enterocolitis 
(Borriello, 1998). The pathogenesis has not been studied specifically in horses, but 
in general terms spores are ingested, convert to vegetative forms in the distal ileum 
and may multiply to high numbers in the colon if the colonization resistance flora 
is disrupted (Jones, 2000). As C. difficile grows, toxins and enzymes that can 
damage tissue are produced. Enterotoxin A appears to act synergistically with 
cytotoxin B (Lyerly et al., 1985). The toxins bind to certain receptors of the 
colonic epithelium, causing damage to the cytoskeleton and disrupting cell-to-cell 
tight junctions. Toxin A also induces chemotaxis of neutrophils, enhancing the 
direct damage resulting in increased capillary permeability, inflammation, fluid 
accumulation and necrosis of the epithelium (Borriello, 1998). A horse can be 
infected with the spores, or possibly the vegetative bacteria, directly from a 
diarrheic horse shedding the bacteria, from the handling personnel, or from the 
environment. Alternatively, proliferation can originate from the horse’s own 
intestinal microflora, where a sparse population of C. difficile may, at least 
transiently, exist asymptomatically. Clinical signs of C. difficile associated 
diarrhea (CdAD) vary from moderate to severe and cannot be used to differentiate 
from other causes of acute colitis. However, Divers (2002) suggests that the 
tympanitic gas distension may be more common in CdAD than with other 
infectious diarrheal diseases in adult horses, and higher mortality has been 
reported in C. difficile toxin-positive horses than in C. difficile-negative horses 
(Magdesian et al., 1997; Weese, Staempfli & Prescott, 2001). 
 
C. difficile was first isolated 1935 from human newborn infants (Hall & 
O’Toole, 1935). Recognition of its pathogenicity to humans appeared considerably 
later. In 1978, several authors associated C. difficile with AAD and 
pseudomembraneous colitis in man (Bartlett et al., 1978; George & Symonds, 
1978; George, et al., 1978; Larson et al., 1978). In a study of an acute diarrhea 
syndrome in the Potomac River area, C. difficile was found in one diarrheic horse 
but also in two healthy horses, and therefore not considered to be primary 
determinant of the diarrhea syndrome (Ehrich et al., 1984). An association with 
enterocolitis in the horse was first described in foals (Jones, Adney & Shideler, 
1987; Jones, Shideler & Cockerell, 1988; Jones et al., 1988). During the past 
decade, there have been several reports, including those subject of this thesis, of C. 
difficile in adult horses with acute colitis, mostly in association with antibiotic 
treatment (Perrin et al., 1993; Cosmetatos et al., 1994; Beier, Amtsberg & Peters, 
1994; Madewell et al., 1995; Magdesian et al., 1997; Båverud et al., 1998; Teale 
& Taylor, 1998; Weese, 2000; Weese, Staempfli & Prescott, 2001; Båverud et al., 
2003).  
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Another important factor with C. difficile is that in humans the infection is 
predominantly nosocomial. The bacteria or their spores have been isolated from 
the hospital environment and from the hands of staff (Kim et al., 1981; McFarland 
et al., 1989). Likewise, C. difficile has been isolated from the environment in 
equine departments of animal hospitals (Weese, Staempfli & Prescott, 2000; 
Båverud et al., 2003).  
 
Foals 
There are several reports on CdAD in foals, although the clinical picture differs 
somewhat from that of adult horses. CdAD in foals is often described to occur 
without prior antibiotic treatment (Jones, Adney & Shideler, 1987; Jones et al., 
1988; Magdesian et al., 1999; Magdesian et al., 2002). However, Beier, Amtberg 
& Peters (1994) reported a C. difficile prevalence of 10.3% in 78 diarrheic foals, 
of which the majority were previously treated with antibiotics. Another reported 
difference in comparison with adults is that faecal samples from foals without 
diarrhea but treated with antibiotics were cultured positive for C. difficile in high 
numbers, with 44% under treatment with erythromycin or gentamicin in 
combination with rifampicin and 15% under treatment with penicillin and/or 
trimethoprim/sulfonamides (Båverud et al., 2003). Interestingly, asymptomatic 
carriers were also identified in 29% (16/56) of healthy foals younger than two 
weeks, whereas all older foals, with one exception, were culture negative 
(Båverud  et al., 2003). In humans, healthy infants are also found to be 
asymptomatic carriers in a high frequency (Hall & O´Toole, 1935; Tullus et al., 
1989). The fact that many foals were younger than two weeks in several of the 
above studies (Jones et al., 1987; Jones et al., 1988; Beier, Amtsberg & Peters, 
1994; Magdesian et al., 2002) makes the association between diarrhea and positive 
cultures for C. difficile in those cases questionable. Groups of healthy untreated 
foals have been found negative for C. difficile (Beier, Amtsberg & Peters, 1994; 
Båverud et al., 1998; Weese, Staempfli & Prescott, 2001; Båverud et al., 2003), 
which corresponds to findings in adult horses. 
 
Diagnosis 
C. difficile infection in adult horses should be strongly suspected in cases of acute 
diarrhea in association with antibiotic treatment and hospitalization. Isolation of 
the bacterium or demonstration of its toxins from faecal samples is required for 
diagnosis of C. difficile infection in humans (Wilkins & Lyerly, 2003). To certify 
the isolation of C. difficile the faecal sample for analysis should be a substantial 
volume (20-30 ml), collected directly from the rectum to prevent contamination 
and packed in plastic bags or cans with excess air eliminated. Ideally the samples 
should be processed within a few hours to minimise influence on survival of 
vegetative bacteria, sporulation rate, and stability of toxins. If sample processing 
must be delayed, freezing at –70 ºC until assay is recommended (Jones, 2000).  
 
When choosing diagnostic methods key aspects to be considered are that both 
nontoxigenic strains (Jang et al., 1997; Magdesian et al., 1997; Båverud et al., 
2003) and strains with only toxin B genes (Magdesian et al., 2002) have been  
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Fig. 1. C. difficile colonies on TCCFA plate.       Fig. 2. C. difficile toxin A test, pos. left,     
Photo:  B.  Ekberg.                    neg.  right.  Photo:  V.  Båverud. 
 
 
 
 
          
Fig. 3 and 4. C. difficile cytotoxin B positive assay left and negative assay right.  
Photo V. Båverud. 
  19 isolated from equine samples. Furthermore, C. difficile toxin production can likely, 
as shown in humans (Karlsson, Burman & Åkerlund, 1999), be down regulated in 
the equine intestinal flora. There may also be a great variation in the degree of 
toxin production in equine isolates, as has been seen in human isolates (Lyerly, 
Krivan & Wilkins, 1988). The laboratory techniques used for diagnosing C. 
difficile include culture of faecal samples on selective agar media, demonstration 
of C. difficile toxin A and B in faecal samples by enzyme immunoassays or by 
tissue culture (mainly toxin B), and detection of toxin A and B genes by 
polymerase chain reaction (PCR) in faecal samples or in isolates. Of importance is 
that none of these tests is a stand-alone test, and that test result has to be 
considered in conjunction with every certain case (Wilkins & Lyerly, 2003). 
 
Other aetiologies 
Clostridium perfringens 
C. perfringens is classified into 5 types, A-E, based on their production of 4 major 
toxins (alpha, beta, epsilon and iota). Some strains of C. perfringens, mainly type 
A, also produce an enterotoxin, CPE. In 1977, Wierup reported an association 
between acute colitis and high counts of C. perfringens type A in faeces and 
intestinal contents of horses, whereas the organism only occurred in small 
numbers (102 colony forming units (cfu)/g) in healthy racehorses. He suggested 
from these findings that intestinal clostridiosis was an enterotoxaemia caused by 
C. perfringens type A. There is an isolated report of acute colitis and death in three 
ponies induced by i.v. injection of CPE (Ochoa & Kern, 1980). However, the 
disease described was not necessarily representative of acute colitis as changes 
could also have been solely due to severe shock. C. perfringens has further been 
demonstrated in other studies as a possible pathogen associated with severe colitis 
in horses (Andersson et al., 1971; Wierup & DiPietro, 1981; Donaldsson & 
Palmer, 1999; Herholz et al., 1999; Weese, Staempfli & Prescott, 2001), and also 
in association with AAD (Andersson et al., 1971; Herholtz et al., 1999; Weese, 
2000). In humans, C. perfringens is mainly known as a cause of food poisoning, 
but there is mounting evidence that enterotoxigenic C. perfringens type A play a 
role in AAD (Borriello et al., 1984) as well as in sporadic cases of diarrhea 
distinct from food poisoning (Mpamugo, Donovan & Brett, 1995). The other C. 
perfringens, namely types B, C and D have also been associated with enterocolitis, 
but only sporadically in foals (Traub-Dargatz & Jones, 1993).  
 
A new toxin produced by C. perfringens, β2-toxin, has recently been implicated 
in equine typhlocolitis (Herholz et al., 1999). That study included 25 horses with 
typhlocolitis, in which β2-toxigenic C. perfringens was detected in samples from 
13 cases (52%) but not from 58 healthy controls.  
 
Diagnosing C. perfringens as a cause of diarrhea in horses is difficult as the 
organism is readily found, though often only in low numbers, in healthy horses 
(Wierup, 1977; Wierup & DiPietro, 1981; Gautsch, 1990; Traub-Dargatz & Jones, 
1993). After other causes of diarrhea have been ruled out, Divers (2002) suggests 
three diagnostic criteria for implicating C. perfringens as a cause of diarrhea; 
finding large numbers of the organism (>105 cfu/ml faeces) in the faecal sample, 
some evidence of sporulation, and presence of enterotoxin in the faeces. This 
  20parallels the tests used in humans for diagnosing C. perfringens antibiotic 
associated diarrhea (Modi & Wilcox, 2001). The enterotoxin is demonstrated in 
faecal samples by enzyme immunoassays, tissue culture assay or alternatively the 
gene is detected by PCR on isolates. As noted above, the presence of β2-toxin may 
be even more relevant. The β2-toxigenic  C. perfringens is demonstrated by 
detection of the gene by PCR (Herholtz et al., 1999).  
 
Other Clostridium species that have been isolated from acute enterocolitis in 
adult horses are C. cadaveris, C. paraputrificum and several unidentified clostridia 
(Staempfli, Prescott & Brash, 1992; Staempfli et al., 1992), but their clinical 
significance at this time is questionable. 
 
Salmonella 
Salmonella is a Gram-negative bacterium with many different spp. of which all are 
considered pathogenic. The serotype with most serious consequences in horses is 
Salmonella Typhimurium. Of particular importance is that Salmonella infections 
are zoonotic, with reports of transmission to staff personnel at an equine hospital 
(Hanche-Olsen, S. personal communication, 1999). Salmonella is also frequently 
implicated in cases of AAD (Owen, 1975; Hird, Pappaioanou & Smith, 1984; 
Staempfli  et al., 1992; Weese, 2000; Weese et al., 2002). Besides antibiotic 
treatment, other factors associated with horses developing salmonellosis or 
shedding of Salmonella include transportation, surgery, hospitalization, 
nasogastric intubation, colic and laminitis (Owen, Fullerton & Barnum, 1983; 
Hird, Pappaioanou & Smith, 1984; Kim et al., 2001). Based on related information 
from other species, it is suggested that horses under stress, such as simply being 
hospitalised, can be infected by doses of Salmonella that are 100-1000 times lower 
than those required to infect clinically normal non-stressed horses (Murray, 1997). 
The clinical picture of acute salmonellosis varies from mild signs of abdominal 
pain, depression and anorexia without diarrhea to peracute fatal colitis. Silent 
carriers have also frequently been identified. One study reported a frequency of 
71.4% (50/70) of horses at slaughter, with fifteen different serotypes isolated 
(McCain & Powell, 1990). However, in reports from outbreaks in veterinary 
hospitals, spread of Salmonella is mostly found to be clonal (Bowen, 2002). In 
some studies of acute colitis, Salmonella was recovered from occasional horses at 
7.8, 15 and 18.9% of the cases examined, respectively (Beier, Amtsberg & Peters, 
1994; Cosmetatos et al., 1994; Magdesian et al., 1997), whereas in other studies of 
colitis no link with Salmonella has been found (Wierup, 1977; Larsen, Dolvik & 
Teige, 1996; McGorum, Dixon & Smith, 1998; Donaldson & Palmer, 1999).  
 
For diagnosis Salmonella is cultured from faecal samples or rectal biopsies on 
selective agar plates directly or after enrichment. A key problem with the 
diagnosis by culture is that with a single culture the recovery of Salmonella is not 
assured, despite presence of the organism. PCR is a more rapid and sensitive test 
and less influenced by faecal consistency (Cohen et al., 1996). Based on studies 
and clinical experience, Cohen and Divers (1998a) recommend that a horse with 
diarrhea be considered negative if two faecal samples for PCR are negative or if 
five faecal cultures are negative. Further, rectal biopsy was reported nearly twice 
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et al., 1985).  
 
Larval cyathostomiasis 
Infection with small strongyles of at least 40 different cyathostome genera called 
larval cyathostomiasis, characteristically results in clinical signs of chronic 
diarrhea and weight loss, but the diarrhea can also be acute and severe (Giles, 
Urquhart & Longstaffe, 1985). The syndrome most often occurs in late winter or 
early spring and there can be a history of incorrect deworming routines. 
Simultaneous maturation and release of inhibited larvae induce inflammation and 
damage of the large intestine mucosa. Clinical diagnosis can be difficult. Faecal 
egg count is of little value since larvae cause the damage, and the burden of egg 
producing adult parasites correlate poorly with the larval burden encysted in the 
mucosa or submucosa. Diagnosis can be made by microscopic evaluation of caecal 
or colonic biopsies, which is rarely collected from horses with colitis. Gentle 
scraping or biopsy from rectal mucosa can occasionally be diagnostically 
rewarding by demonstration of larvae (Cohen & Divers, 1998a). Response to 
treatment with anthelmintic may also be of diagnostic value and it is worthy of 
note that these horses rarely die acutely of colitis. 
 
Ehrlichial colitis 
Potomac horse fever is an infectious colitis caused by a rickettsial organism, 
Ehrlichia risticii. The disease was first reported in the area of Potomac River in 
Maryland, and is now enzootic in the United States USA (Palmer, 1992b). The 
disease is minimally contagious, seasonal, and risk factors such as stress and 
antibiotic treatment is not believed to contribute to the genesis of the disease. It 
has been reported in Europe (van der Kolk, Bernadina & Visser, 1991) but never 
found in Sweden.  
 
Other infectious causes and non-infectious causes 
Additional infectious agents that have been associated with diarrhea in adults 
include  Aeromonas spp. (Hathcock et al., 1999), Mycobacterium avium, 
Aspergillus and Histoplasma spp. (Divers, 2002). 
 
Acute diarrhea in the adult horse has also been associated with non-infectious 
causes, such as toxicity to phenylbutazone, intoxication by cantharidin, plants, and 
other compounds, carbohydrate overload, or dietary changes. Finally, conditions 
such as granulomatous enteritis, intestinal lymphosarcoma, peritonitis, anaphylaxis 
and stress can also manifest with diarrhea in the horses (Murray, 1997).  
 
General principles of treatment 
The description of principles of treatment for horses with acute colitis is well 
documented in different textbooks and review papers (Palmer, 1992a; Murray, 
1997; Cohen & Divers, 1998b; Divers, 2002). Apart from some selected causes, 
the treatment is mainly supportive.  
 
 
  22Fig. 5. Diarrheic horse on continous fluid treatment, note use of thoracic vein.  
Photo: B. Ekberg. 
 
 
Fluid and electrolyte therapy 
The most important treatment for horses with acute colitis is fluid replacement 
therapy to correct the fluid and electrolyte deficiencies. A balanced polyionic 
crystalloid solution is preferred. The need of fluid depends on volume replacement 
(which in litres is the percentage of dehydration x body weight in kg), the 
maintenance needs (which are 60-100 ml/kg and day) and estimation of ongoing 
losses (highly variable and difficult to estimate). A major challenge with fluid 
therapy is simply being able to deliver them (through one, or even several flow 
limiting venous catheters) at a sufficiently rapid rate to combat the ensuing shock. 
If perfusion is particularly compromised and shock is clearly apparent, initial 
treatment with hypertonic saline or colloid solutions is indicated. If hypertonic 
saline is given, it must be followed up with administration of large volumes of 
crystalloids, since fluid will be drawn into the intravascular space and otherwise 
the extravascular dehydration will be aggravated. If on the other hand colloids are 
selected, they have the advantage that the majority of the administered volume 
remains within the intravascular space for an extended period and helps draw 
fluids from other compartments into the intravascular space. Plasma can also be 
used as the ultimate ‘colloid’ as it, in additional to providing fluid support, 
contains critical coagulation factors that can be lost with the protein exudation 
through damaged intestine. Potassium should be added to the fluid since anorexia 
and the losses through diarrhea and urine can cause severe total body potassium 
deficit. If signs of hypocalcemia occur, such as diaphragmatic flutter, calcium 
borogluconate can be added. A mild to moderate acidemia can be corrected by the 
rehydration, but if more severe metabolic acidosis, correction of acid-base with 
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bicarbonate solution is preferable. Administration of fluids orally is seldom a 
feasible alternative as these horses can have altered intestinal motility and, on 
occasion, gastric reflux. Further, the uptake of fluid from the intestine can be 
reduced and there is an increased risk of bleeding with nasogastric tubing of these 
patients due to disturbance of the coagulation system.  
 
Anti-inflammatory therapy 
Treatment to help negate the effects of endotoxin/systemic inflammatory response 
should be routinely provided to all colitis cases. Non-steroidal anti-inflammatory 
drugs (NSAIDs) may be indicated both for analgesic and antiendotoxic effects, 
even though these drugs should be administered with caution because of the 
increased risk of toxic side effects due to concurrent hypoproteinemia and 
dehydration. A lower than label dose of flunixin meglumine, (0.25 mg/kg q6h) 
was shown to be equally effective compared to full label dose at reducing the 
eicosanoid production and lactic acidosis (Semrad et al., 1986).  
 
Antidiarrheic agents 
Reduction of diarrhea has been attempted pharmacologically on many fronts, 
including slowing of intestinal content transit time, altering the balance of 
absorption/secretion, administration of substances that may bind with or block 
effects of toxic entities in the intestinal lumen, and even attempts to introduce 
‘healthy’ bacteria. While all of these modalities continue to be favoured in 
selected clinical settings, none as yet have any scientifically based evidence for 
benefit in the adult horse. Perhaps the most promising idea to date in this area is 
the use of biotherapy to support the intrinsic intestinal flora with use of different 
probiotics, as would be discussed further below. 
 
Antibiotic therapy 
Antibiotic therapy is generally controversial in horses with acute colitis, since in 
many cases antibiotics are actually associated with the development of disease. 
The general recommendation for horses with AAD is to immediately discontinue 
the antibiotic treatment. However, in severe cases where the risk for septicaemia is 
said to be high, antibiotic treatment may be indicated. Furthermore, when a 
clostridial organism is suspected or diagnosed to be a contributing factor of the 
diarrhea, treatment with antibiotics has been suggested. Metronidazole or 
vancomycin are drugs of choice for C. difficile associated diarrhea in humans, and 
the former has been reported effective in horses with colitis. In a study by 
McGorum, Dixon & Smith (1998), eight horses with colitis treated with 
metronidazole survived whereas five of seven not treated with metronidazole died. 
Vancomycin treatment of C. difficile associated diarrhea, alone or following 
metronidazole when the latter failed to produce a clinical response, resulted in 
resolution of diarrhea in 12 of 14 horses, whereas treatment with only 
metronidazole was successful in five of seven horses (Magdesian et al., 1997). 
Beneficial effects involving treatment of experimentally induced acute colitis with 
bacitracin have also been described (Staempfli et al., 1992). Interestingly, there 
are conflicting results concerning C. difficile and susceptibility to antibiotics. 
Whereas all C. difficile isolates tested were susceptible to metronidazole and   25 
vancomycin in some studies (Weese, Staempfli & Prescott, 2001; Båverud et al., 
2003), others have reported over 40% of equine C. difficile isolates to be 
metronidazole resistant (Jang et al., 1997). A high percentage of resistance to 
bacitracin by equine C. difficile isolates has also been reported (95 - 100%) (Jang 
et al., 1997; Weese, Staempfli & Prescott, 2001; Båverud et al., 2003), and 
therefore this drug does not appear appropriate for treating C. difficile confirmed 
cases. For Salmonella, antibiotic treatment probably has little or no positive effect 
in adult horses. 
 
Additional treatment 
The nursing and management of the colitis cases are important. Because horses 
with colitis have the highest rate of jugular thrombosis of any equine patient 
(Divers, 2002), the choice and site of the indwelling catheter is important. 
Polyurethane or silicone are least irritating materials and the thoracic vein could be 
preferred as site of the catheter (see Fig. 5), especially if jugular thrombosis has 
already occurred. As colitis is markedly catabolic, efforts should be made to 
increase feed intake by offering palatable feedings and other nutritional support.  
 
The equine intestinal microflora  
The normal intestinal microflora 
A newborn foal has a sterile gastrointestinal tract. Foals at the age of 4 days are 
already colonised by cellulolytic bacteria, which soon occur in the same number 
per ml of intestinal contents as in adult horses (Julliand, 1998). Though 
colonization of microorganisms starts immediately, the intestinal flora with its 
complex populations is not fully established until after weaning. This is reflected 
by the fact that a predominantly milk-fed foal is much less sensitive to the adverse 
effect of antibiotic treatment such as severe diarrhea (Båverud et al., 1998; 
Freestone, 2002). More than 500 bacterial species have been isolated from the 
intestines of humans in the colon and more than 99% are anaerobic (Kerr, 1991; 
Vollaard & Clasener, 1994). While detailed studies of the equine intestinal 
microflora are lacking, the same condition most probably exists in horses with a 
great variety of species and dominance of anaerobes (Jones, 2000). In a study on 
the equine gastrointestinal tract, a substantial culturable bacterial population was 
even found in the proximal duodenum (2.9 x 106/g faeces) and the number 
progressively increased distally through the small intestine (jejunum, 29.0 x 106 
and ileum, 38.4 x 106). The total bacterial counts were highest in the caecum (25.9 
x 108) then declined slightly in the colon (6.1 x 108) confirming that these are the 
main sites for microbial colonization and fermentation. There were also 
differences in the pH, increasing along the small intestine, probably due to 
excretion of bicarbonate from pancreas and intestinal secretion, and then 
decreasing in the hindgut due to VFA production. Additionally, the presence and 
proportions of VFA varied in the different intestinal segments investigated 
(Mackie & Wilkins, 1988).  
 
The cellulolytic bacteria identified in the equine large intestine are, amongst 
others, Ruminococcus flavefaciens and Fibrobacter spp. (Julliand et al., 1999). By   26
use of group-specific oligonucleotide probes the horse colonic microflora was 
recently quantitatively analysed. The predominant bacterial groups identified were 
Spirochaetaceae, the Cytophaga-Flexibacter-Bacteroides group, the Eubacterium 
rectale-Clostridium coccoides group and an unknown cluster of Clostridium spp. 
Each of these groups accounted for about 10 to 30% of the colonic microflora. 
Other bacterial groups identified were, amongst others, the Bacillus-Lactobacillus-
Streptococcus group and Fibrobacter (Daly & Shirazi-Beechey, 2003). 
 
Function of the intestinal microflora 
Microbial digestion is the most important function of the equine intestinal 
microflora. In the large intestines microorganisms ferment cellulose into short-
chained VFA, which are absorbed through the intestinal wall. Microbial digestion 
is influenced by the availability of substrate, retention-time of digesta, and 
anaerobic and pH conditions (Argenzio, 1975). 
 
The normal intestinal microflora also acts as a barrier against colonization of 
exogenous potentially pathogenic bacteria and against overgrowth of already 
present opportunistic bacteria. This is referred to as colonization resistance (CR) 
(Vollaard & Clasener, 1994). There are different theories regarding the 
mechanisms of the protective function of the normal microflora, including 
bacterial competition for adhesion to receptors, steric hindrance of other receptors 
when bound, production of antibacterial products, lowering of the pH by VFA 
production and competition for substrates (Jones, 2000). Host factors are also 
important for CR. Different anatomical and physiological CR factors (intact 
mucosa, salivation, swallowing, secretion of immunoglobulin A, production of 
gastric acid, desquamation of cells of the mucous membranes and normal 
gastrointestinal motility) hinder bacterial adhesion to the mucosa and accelerate 
gastrointestinal transit time (Vollaard & Clasener, 1994).  
 
Disruption of the intestinal microflora 
Antibiotic administration is the most common and significant cause of 
disturbances in the human normal intestinal microflora (Nord, 1993). 
Experimental work in mice indicated that CR decreased to extremely low values 
during antibiotic treatment as a result of the suppression of the anaerobic fraction 
of the intestinal flora (van der Waaij et al., 1977). Disturbance of the colonization 
resistant microflora may allow selection and proliferation of potential pathogenic 
bacteria resistant to the antibiotic used. The pathogen could already be present 
within the large intestine or be acquired from the environment. A third possible 
mechanism is that CR is lowered by the antibiotic treatment, while at the same 
time the pathogen is also inhibited but not killed and thus colitis may develop after 
the treatment is discontinued and the pathogen has repopulated the colon. Spore 
formation might be important in this mechanism (Fekety et al., 1979).  
 
Both episodic feeding and abrupt change of diet can markedly affect the 
microbial population (Goodson et al., 1985; Clarke, Roberts & Argenzio, 1990). It 
is possible that a similar course of events takes place in the equine intestines as 
those found in the bovine rumen. The pathophysiology of carbohydrate overload   27 
can then be described by increased acid production that overwhelms buffer 
capacity, resulting in a shift of bacterial population to lactic-acid producers instead 
of VFA producers. The acid and hyperosmolality damage colonic mucosal barrier 
and endotoxins are absorbed. Mucosal mast cells respond to acid by releasing 
histamine, which causes increased capillary permeability and submucosal oedema 
formation (Clarke, Roberts & Argenzio, 1990).  
 
In order to restore the balance when the microflora is disturbed, one theory has 
been to exchange it with normal flora. Earlier it was common to treat horses with 
chronic diarrhea with a suspension of normal horse faeces via nasogastric tubing. 
No valid evaluation of this treatment has been done, but these ideas are based on 
the belief of the importance of the normal anaerobic flora to maintain normal 
intestinal ecology. Successful treatment with rectal infusion of normal faeces in 
human patients with relapsing C. difficile enterocolitis has been reported (Schwan 
et al., 1984; Tvede & Rask-Madsen, 1989). Furthermore, a reduction of C. difficile 
and prevention of caecitis were observed in hamsters given caecal homogenates 
both orally and rectally (Wilson, Silva & Fekety, 1981). Enemas are not feasible to 
carry out in horses due to the anatomy of the gastrointestinal tract. Another 
method frequently used to achieve positive effect on the microflora is by giving 
probiotics, in the form of live microbial feed supplements. (e.g. Lactobacillus spp., 
coliforms, and yeasts) which could have a supportive effect on the intestinal flora. 
Still, proof of their efficacy in horses is lacking and possibly the effect, if any, is 
more of a preventive character rather than therapeutic, at least in such a severe 
condition as acute colitis in horses. In human patients, the incidence of antibiotic 
associated diarrhea has been reduced by treatment with the yeast Saccharomyces 
boulardii (Surawicz et al., 1989). As well, decreased recurrence rate of C. difficile 
infection has also been shown after treatment with the above noted yeast 
(Surawicz et al., 2000) and with Lactobacillus rhamnosus (Pochapin, 2000). 
 
Methods for examination of the intestinal microflora 
Little is known of the intestinal microbial population, the significance of specific 
changes and findings in the microflora and the complexity of interactions between 
the microbes and the host animal. Most of the information on the colonic 
microflora comes from studies of faecal samples, in which the microfloral 
composition may differ considerably (Kerr, 1991). Besides examination for 
specific or potential pathogens, investigation of the intestinal microflora has been 
directed to certain bacteria or groups of bacteria, of which changes have been 
judged to be indicative of disturbance of CR. In humans, impairment of CR may 
be indicated by an increase in the numbers of Gram-negative bacilli, enterococci 
and yeasts in faecal samples or by facilitation of colonization by a challenge strain 
(Vollaard & Clasener, 1994). However, the microfloral composition that provides 
CR is probably not directly comparable between different species.  
 
In thesis work from 1977, Wierup established a method for examining of the 
equine intestinal microflora. The parameters investigated in this method were pH, 
the number of C. perfringens, α-Streptococcus, β-Streptococcus, Bacillus, moulds 
and coliform bacteria. Besides the main finding of high counts of C. perfringens in 
horses with diarrhea, no other parameter differed significantly between healthy   28
and sick horses, which was also shown in another report (Wierup & DiPietro, 
1981). Similar results were observed in a later study of the correlation between 
faecal bacteriologic examination of the parameters described above and clinical 
signs. A correlation between high counts of clostridia and clinical signs of diarrhea 
or colic was found, but no correlation was present between counts of coliform 
bacteria and clinical signs (Wiberg, 1994).  
 
The background for studying the number of intestinal coliforms was a 
correlation found between abnormal values of coliform counts and a disease 
causing certain skin changes (Månsson, 1957). Further, that study reported that 
horses with abnormal faecal consistency often had lower faecal coliform counts. 
Ronéus et al. (1993) determined counts of coliform bacteria in faecal samples 
before and after oral treatment with a commercial product containing Escherichia 
coli suspension, but did not find significant changes. Other authors have also used 
similar and some additional parameters in studies of the impact of antibiotic 
treatment on the intestinal microflora in horses (White & Prior, 1982; Horsepool, 
Taylor & McKellar, 1994). White & Prior (1982) noted appearance of C. 
perfringens type A, disappearance of Veillonella, and large increases in counts of 
Streptococcus spp., Bacteroides spp., and coliform bacteria after treatment with 
oral oxytetracycline. These changes were not observed after TMP/SDZ treatment. 
However, the study was performed on only three individuals in each group and 
different horses were used for the two antibiotics compared. The counts of 
Lactobacillus spp. were unaffected after both treatments.  
 
Other methods for studies of the intestinal microflora, besides enumeration and 
isolation of microbes include investigation of capability, the enzymatic capacity of 
the microflora, and performance, for example production of short-chain fatty acids 
(Collinder, 2001). This work in horses is only in its infancy and the significance of 
findings remains to be further evaluated. 
 
A great portion of humbleness has its place in evaluation of results from faecal 
bacteriologic examinations. It is important to have in mind that only a very small 
part of the intestinal microflora is examined and even isolation of a specific 
pathogen does not provide its definitive role in the pathophysiology (Roberts, 
1990). C. perfringens, and even on occasion C. difficile and Salmonella may be 
cultured from healthy horses or from sick horses without being the causative 
agent. History and clinical signs must always be added to the interpretation of the 
bacteriological result. With more sensitive detection methods, such as PCR, it is 
possible that the isolation of these pathogens would be facilitated, as a healthy 
horse may house the bacteria in such a low number that it is below detection limit 
for culturing. In this thesis, however, conventional methods such as bacteriological 
culturing and toxin detection have been used to study changes in the intestinal 
microflora.  
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Aims of the study 
 
The principal aim of the investigations was to evaluate the impact of antibiotic 
treatment on the equine intestinal microflora with special interest in occurrence of 
C. difficile and the risk for development of antibiotic associated diarrhea in adult 
horses.  
 
 
The specific aims were as follows: 
 
►  To determine the impact of antibiotic treatment on the large intestinal 
microflora in horses with and without colitis, in particular the association 
with C. difficile. 
 
►  To determine whether low doses of erythromycin and/or rifampicin could 
induce acute colitis. 
 
►  To assess current dosage regimens for TMP/SDZ with focus on the 
influence of the antibiotic combination on the intestinal microflora. 
 
►  To further assess the role of C. difficile as an enteric pathogen by 
experimental oral infection. 
 
►  To assess if penicillin treatment affects the establishment of C. difficile.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   30
Comments on Material and Methods 
 
Animals and sampling 
Horses 
In a case control study, Paper I, 208 mature horses of different breed, gender and 
age were sampled. The diseased horses were sampled at animal hospitals, animal 
clinics and in general practice, whereas the group of healthy horses, in total 140, 
also were sampled from riding schools, private stables, trotting camps and stud 
farms in order to broaden the material.  
 
All animals used in the experimental studies, Papers II-IV, were owned by the 
Department of Large Animal Clinical Sciences. Altogether 22 horses were used, 
comprising 20 standardbreds, one Swedish Warmblood and one Icelandic horse. 
Different breeds were used by necessity, as there were some difficulties with 
accessibility of horses due to economic constraints. However, breed was not 
thought to affect the outcome of studies on the intestinal flora. Horses were of 
both genders, aged 4-16 years, weighing 375-558 kg, healthy on clinical 
examination and had normal routine haematology and blood biochemistry before 
the experimental studies. All horses were given their customary feed and were 
never starved. When studying the impact of antibiotic treatment on the intestinal 
flora it is considered important not to change the feed or to starve the horse as this 
may alter the composition of the flora (Argenzio, 1975; Goodson et al., 1985; 
Roberts, 1990). In Paper II and IV the horses were isolated due to an increased 
risk of faecal spreading of bacteria. Since the experimental studies involved some 
elements of risk to the horses, they were examined for vital signs (temperature, 
pulse, respiratory rate, mucous membranes), appetite and faecal consistency twice 
to four times daily through the experiments (Paper II, III and IV) because of the 
risk of inducing acute colitis, a syndrome that can develop peracutely. 
 
All studies were approved by the Ethical Committee for Animal Experiments.  
 
Sampling 
Faecal samples were taken from the rectum, placed in plastic containers or thick 
plastic bags without excess air and processed, apart from one exception, within 4 
h. In Paper I, group 2 and 3, comprising horses without signs of enteric disorders, 
a majority of the samples were processed within 8 h and a few within 24 h (not 
cultured). Portions of the samples were frozen at –20 ºC for analyses of C. difficile 
toxins, and, in Paper II, for assay of antibiotic concentrations. 
 
Blood samples for analysis of antibiotic concentrations were collected from the 
jugular vein using vacutainer system (Paper II and III) or through a catheter for the 
intense sampling following completion of drug administration (Paper III). The 
samples were collected in glass tubes, refrigerated and centrifuged then held 
frozen (-70 ºC and –20 ºC) until assayed. 
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General study design 
Study I 
This study was designed as a case control study. Bacteriological examinations of 
faecal samples were performed on 208 horses classified into four categories. 
Group 1: horses that developed colitis during antibiotic treatment (n=25), group 2: 
horses without signs of enteric disorders (n=140), group 3: horses without signs of 
enteric disorders but treated with antibiotics (n=21) and group 4: horses with 
colitis but not treated with antibiotics (n=22). The antibiotic treatments were of 
different kinds and administered by different routes. The purposes were to study 
the impact of antibiotic treatment on the intestinal flora in mature horses with and 
without colitis and to observe whether antibiotic treatment favoured growth of 
specific pathogens, such as C. difficile.  
 
Study II 
Study II was designed to study the impact of very small oral doses of 
erythromycin and rifampicin on the intestinal flora in mature horses and to assess 
whether colitis could be induced by this treatment. Six horses were used, one of 
which was used on two occasions. Mixtures of erythromycin and rifampicin 
(Abboticin® 1.25 mg/kg, q8h and Rifadin® 0.25 mg/kg, q12h) were administered 
orally with syringes for 5 days to mimic accidental intake. One horse at a time was 
studied. As horse No. 1 developed severe colitis on the third day of antibiotic 
treatment, the impact of even lower dosages was evaluated in horse No. 2 
(erythromycin 0.125 mg/kg and rifampicin 0.02 mg/kg). The following three 
horses were given only rifampicin and the last two horses were given only 
erythromycin in order to further evaluate which antibiotic causes the severe 
disturbances of the intestinal flora or if it has to be the combination of the two. 
Each horse served as its own control, with samples taken before onset of the 
antibiotic administration. Faecal and blood samples were henceforth taken for 
bacteriological examinations and determination of drug concentrations and the 
horses were checked for vital signs, appetite and faecal consistency. 
 
Study III 
The objective of this study was to assess dosage regimens of two formulations of 
trimethoprim/ sulfadiazine (TMP/SDZ) to horses with focus on the influence of 
this antibiotic combination on the intestinal flora and determination of the binding 
of TMP/SDZ to equine plasma proteins, the plasma concentrations and 
pharmacokinetic parameters for TMP/SDZ. Veterinary products with TMP/SDZ in 
Sweden are labelled for administration once daily but a pilot study showed that 
remarkably low antibiotic concentrations were obtained with recommended dosing 
(Ingvast-Larsson, C. personal communication, 1994). The combination of 
TMP/SDZ is one of the most widely used antibiotics for horses. TMP/SDZ has 
traditionally been considered potent to easily disturb the intestinal flora (Wilson et 
al., 1996) and there was a hesitation among clinicians in Sweden to increase 
dosing despite studies performed in other countries (Bertone et al., 1988; Brown, 
Gronwall & Castro, 1988, van Duijkeren et al., 1994) which lack mention of any   32
such adverse effects. TMP/SDZ was given orally and i.v. (Hippotrim® paste and 
Hippotrim® injection solution) for 5 days in labelled dosing (30 mg/kg p.o. and 15 
mg/kg i.v.) but twice daily instead of once. The drug administration was 
performed on six horses, three horses at a time, beginning with the oral route. The 
horses were examined for vital signs, appetite and faecal consistency, and had 
faecal and blood samples taken for bacteriological examination and determination 
of drug concentrations. Two faecal samples from each horse were taken prior to 
antibiotic administration as time zero controls. Plasma concentrations and 
pharmacokinetic parameters of i.v. and oral administrations were measured and 
compared. Statistical calculations were performed using Wilcoxon´s signed rank 
test for paired samples. A non-parametric method was used as it gives a more 
representative result when using small numbers of animals in a study. 
 
Study IV 
The role of C. difficile as a potential enteric pathogen and the causal connection 
between C. difficile and prior antibiotic treatment were studied by an experimental 
oral infection model. In the first phase of the study a total of eight horses were 
administered C. difficile orally in broth and changes of vital signs, appetite and 
faecal consistency, and eventual excretion duration of C. difficile were monitored. 
After a period of at least four weeks had elapsed to allow stabilisation of the 
intestinal flora, the horses underwent a second inoculation of C. difficile after 
being pre-treated with penicillin procaine (Penovet®) intramuscularly at labelled 
dosing (20 mg/kg) q24h for 3 days. Faecal samples for bacteriological 
examinations were taken twice before inoculation, as time zero controls, then 
twice daily up to ten days post inoculation. In both studies experimental 
inoculation was performed on two horses at a time, with an additional horse as a 
control which underwent identical procedures as the experimental pair but was 
given only broth without C. difficile. The paired t-test was used for statistical 
calculations.  
 
Bacterial culture and identification 
Clostridium difficile (Paper I, II, III, IV) 
The samples were cultured on taurocholate cycloserine cefoxitin fructose agar 
(TCCFA), incubated anaerobically at 37 ºC and the plates were read after 48 and 
96 h. This selective agar contains taurocholate, which facilitates outgrowth of 
spores, and cycloserine and cefoxitine, suppressing growth of other bacteria but 
not C. difficile (George et al., 1979; Wilson, Kennedy & Fekety, 1982). Without 
selective agar or spore selection methods like heat shock or use of alcohol, C. 
difficile is difficult to detect, as it grows slowly and is readily overgrown by other 
bacteria, thereof the name. 
 
Initially, two other methods for culturing were used to further enhance the 
growth of C. difficile. Faecal material was inoculated in broth suspension and 
incubated anaerobically at 37 ºC for 48 h before spread onto TCCFA-plates.   33 
Moreover, inoculation onto C. difficile-agar was also performed. These two 
methods did not improve the results of culturing and so were discontinued.  
 
Identification of C. difficile was done based on typical growth and morphology. 
The colonies are 4-8 mm in diameter, flat and yellow with an irregular edge 
surrounded by a visible yellow margin. Additionally, colonies have a characteristic 
smell of horse stables and show yellow fluorescence under ultraviolet light. 
Further identification, as for other anaerobes was performed, including 
biochemical tests and gas-liquid chromatography (Holdeman, Cato & Moore, 
1977).  
 
Other clostridia (Paper I, II, III)  
Faecal samples were cultured on fastidious anaerobe agar (FAA) with 5% 
defibrinated horse blood and incubated anaerobically at 37 ºC for 24 and 48 h 
(Holdeman, Cato & Moore, 1977) for growth of Clostridium spp. other than C. 
difficil,e with special focus on C. perfringens. Identification of C. perfringens was 
based on noting typical double-zoned hemolysis, Gram stain and positive 
lecitinase test. This culture was performed as a complement to the quantitative 
examination for confirmation of the diagnosis of C. perfringens. Only the portion 
of the samples in Paper I suitable for further processing was examined.  
 
Quantitative bacteriological and mould examination (Paper I, II, III) 
These studies started from a Swedish perspective where, since according to work 
by Wierup (1977) and Wierup and DiPietro (1981), a quantitative bacteriological 
examination has been in general use for demonstrating changes in the numbers of 
certain bacterial species, considered indicative of disturbances in the faecal 
microflora associated with diarrhea in horses. Culture of the samples must begin 
within 4 hours of collection in order not to avoid confounding influence of time on 
the relative quantities of the different bacteria being quantified. Due to this factor, 
not all samples in Paper I were examined. Counts of cfu/g faeces of lecitinase-
positive clostridias, coliform bacteria, Bacillus spp. and moulds were performed. 
Faecal pH was also measured. 
 
Salmonella (Paper I, II, III) 
Approximately 3 g of faecal material was inoculated into selenite broth and 
incubated aerobically overnight at 37 ºC. The following day the broth was 
streaked on brilliant green agar and xylose-lysine-desoxycholate agar and 
incubated aerobically for 24 h at 37 °C. Colonies with morphology consistent with 
Salmonella were identified according to Kauffman and White. In Paper I, only 
samples from diarrheic horses were examined.  
 
C. difficile toxin assay 
In Paper I, II, III and IV, a tissue culture based assay was used for detection of C. 
difficile toxin B. Frozen samples were thawed at room temperature.   34
Approximately 1 ml of faeces was diluted in phosphate buffered saline (PBS), 
centrifuged and filtered through a sterile filter, and a 20 µL aliquot placed in wells 
with cell culture. Human diploid fibroblast cells were used for the main part of 
investigations. However, the initial studies were made at the Karolinska Institute, 
Stockholm, Sweden, with use of human embryonal intestinal cells. After 
incubation the effect of the faecal dilutions on the cells was assessed by 
microscopy, and a positive result was recorded when cytopathogenic effect was 
observed in at least 50% of the cells. This was confirmed by neutralisation with C. 
difficile antitoxin B. Both negative (PBS) and positive controls (a previous 
positive sample) were also included for each cell culture test for control of test 
performance. This method is considered reliable but time-consuming and costly.  
 
For detection of C. difficile toxin A (Paper IV), a commercial immunoassay for 
direct qualitative detection (C. difficile toxin A test, Oxoid Ltd, Basingstoke, 
England) was performed. The sample was diluted, centrifuged and the supernatant 
added to the test unit, which contains monoclonal antibodies to C. difficile toxin A 
labelled with blue latex beads. Once bound the antigen-antibody complex travels 
through the test strip by capillary action to an area containing an immobilised line 
of anti C. difficile toxin A antibody. There the antigen-antibody-latex complex 
binds to the fixed antibody, which is shown by the formation of a blue line. This 
test procedure takes less than an hour, has a high specificity (97.8%) and 
sensitivity (90.4%) and is relatively inexpensive. 
 
C. difficile inoculation (Paper IV) 
For the experimental infections, an inoculum consisting of both spores and 
vegetative forms of C. difficile was used originating from a C.difficile strain 
isolated from a horse in study II and known to produce toxins A and B. For spore 
forms, colonies were selected from TCCFA-plates, placed in 250 ml of anaerobe 
broth (Båverud et al., 2003) and incubated for 48 h at 37 °C to promote growth, 
then for a further 5 days in room temperature. Sporulation occurs when the 
conditions for growth become unfavourable. For vegetative forms, additional 
colonies were selected, placed in broth and incubated in the same way for 48 h, 
then streaked on FAA-plates and incubated for another 4 days before being 
harvested in 10ml broth. The horses were sedated with detomidine and a 
nasogastric tube was passed into the stomach. A thin plastic tube with a syringe 
adaption on the outer end was placed inside the ordinary tube and the two bacterial 
broth cultures (250 ml and 10 ml with an estimated number of C. difficile of 107-
108 cfu/ml) were administered into the stomach via a syringe. The tube was 
flushed with 1L of NaHCO3, pH 7, to increase pH in the stomach in order to assist 
bacterial survival. 
 
Assay of antibiotics 
Agar well diffusion (Paper II) 
To determine whether measurable concentrations of erythromycin and rifampicin 
were attained in serum and faeces after low dosing, erythromycin and rifampicin   35 
in serum and faeces were assayed according to a modified agar well diffusion 
method (Chapin-Robertsson & Edberg, 1991). Two test organisms, each resistant 
to one of the antibiotics, were used. Standard dilutions of the antibiotics were 
prepared in serum and faeces dissolved in PBS. Samples, together with serum and 
faecal standards were set in duplicate on the same agar plate, and then incubated 
for 16h at 35 ºC prior to reading. The mean values of the inhibitory zone diameters 
were recorded. The sample concentrations were calculated from a log-linear plot 
of concentration versus zone-diameter of a range of standards.  
 
HPLC (high pressure liquid chromatography) (Paper III) 
The plasma concentrations of sulfadiazine (SDZ) and trimethoprim (TMP) were 
determined by normal phase HPLC. A modified method described by van 
Duijkeren (1994) was used. In order to precipitate the plasma proteins, acetonitrile 
was added to plasma samples and the supernatant was decanted after 
centrifugation. The acetonitrile was evaporated and the residue dissolved in 
mobile phase before being injected and analysed by the HPLC-system. The mobile 
phase is transferred to an UV-detector with wavelength of 289 nm, where both 
drugs have absorbance. The absorbance is proportional to drug concentration, 
which were established by comparison to standards.  
 
Plasma protein binding (Paper III) 
For determination of binding of SDZ and TMP to plasma proteins, equilibrium 
dialysis was used. Pooled plasma was dialysed until reaching a state of equilibrium 
against buffer with set concentrations of SDZ (100 µg/ml and 10 µg/ml) and of 
TMP (10 µg/ml and 1 µg/ml). Prior to the dialysis, pH was adjusted to 7.4 and the 
cells were gassed with CO2 and sealed to maintain constant pH. This step is 
particularly important since pH rises with handling of plasma due to loss of CO2 
and as the plasma protein binding is dependent on pH (Brørs et al., 1983), and 
changes therein can affect results. The concentrations in plasma and buffer were 
determined from the dialysis cells. The fraction of free drug is the ratio of drug in 
buffer and total drug in plasma.  
 
Pharmacokinetic analysis (Paper III) 
The plasma concentration-time data after the final i.v. and oral administrations of 
TMP/SDZ were analysed using a computer programme, PCNONLIN, version 4.2. 
A two-compartment model was chosen for the i.v. administration. The goodness of 
fit was assessed by sum of residuals. The weighing factors for SDZ and TMP were 
chosen on basis of the lowest standard error of the estimates. The use of weighing 
factor is necessary when there are large differences in the concentration values. 
Without weighing factors, excessive emphasis is given the higher values and the 
curve will fit the lower values less well. A noncompartmental analysis was used 
for the concentration-time data obtained after oral administration.  
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Results and Discussion 
 
C. difficile in association with AAD (Paper I, II) 
The impact of antibiotic treatment on the equine intestinal flora was demonstrated 
in study I, where 40% (10/25) of horses that developed acute colitis during 
antibiotic treatment proved positive for C. difficile by faecal culture and/or 
cytotoxin assay. C. difficile was not found in faecal samples from horses with 
colitis that were not treated with antibiotics, nor in any of the horses in the groups 
without signs of enteric disorders regardless presence or absence of antibiotic 
treatment. A similar prevalence (26-42%) of C. difficile among AAD cases 
diagnosed by positive culture and/or detection of toxins A and/or B is reported by 
others(Magdesian et al., 1997; Weese, 2000; Båverud et al., 2003). This is in 
agreement with studies in humans where C. difficile is believed to be the causative 
agent in 15-55% of AAD cases (Bartlett, 1990; McFarland, Surawicz & Stamm, 
1990; Lyerly, 1995; Svenungsson, Lagergren & Lundberg, 2001; Wiström et al., 
2001). There are also reports of C. difficile associated diarrhea (CdAD) in horses 
that lack clear documentation of concurrent antibiotic use, showing an association 
level of 14 to 25.4% (Donaldson and Palmer, 1999; Weese, Staempfli & Prescott, 
2001). Cases of CdAD in the absence of antibiotic use are however a relatively 
minor proportion of diagnosed cases (Beier, Amtsberg & Peters, 1994; Cosmetatos 
et al., 1994; Magdesian et al., 1997; Båverud et al., 2003). This figure is 
consistent with findings in humans and laboratory animals (Svenungsson, 
Lagergren & Lundberg, 2001; Rehg & Lu, 1982). Furthermore, C. difficile appears 
to be present in very low numbers (Cosmetatos et al., 1994), or not at all, as 
shown in study I, (Donaldson & Palmer, 1999; Weese et al., 2001; Båverud et al., 
2003), in the intestinal tract of healthy adult horses. 
 
Thus, a strong association between C. difficile and AAD in horses was shown in 
this study, which also is reported elsewhere (Beier, Amtsberg & Peters, 1994; 
Cosmetatos et al., 1994; Madewell et al., 1995; Magdesian et al., 1997; Weese, 
2000; Weese, Staempfli & Prescott, 2001; Båverud et al., 2003). This is in 
agreement with human medicine, where this association is clear (Kim et al., 1981; 
Bartlett, 1990; McFarland, Surawicz & Stamm, 1990; Tabaqchali & Jumaa, 1995; 
Wiström et al., 2001;). Additionally, C. difficile in man is mainly a nosocomial 
infection (Nolan et al., 1987; McFarland et al., 1989). This link to nosocomial 
infections in the horse, discussed by others (Cosmetatos et al., 1994; Madewell et 
al., 1995), also arises in study I, where eight of ten horses contracted C. difficile at 
an animal hospital or had recently been hospitalized. Furthermore, Madewell et al. 
(1985) reported an outbreak of C. difficile-associated diarrhea in nine horses in a 
veterinary medical teaching hospital, where ten horses developed diarrhea within 
two days, pointing strongly to nosocomial infection. All horses were treated 
previously with antibiotics. Otherwise, apparent outbreaks of C. difficile diarrhea 
in adult horses are rarely reported.  
 
Outbreaks of acute colitis with unknown aetiology have been reported, with 
three cases from the same stable within nine days (Bergsten & Lannek, 1970), 
three cases at the same equine clinic in a week (Cook, 1973) and six cases in a   37 
week at the Region Animal Hospital, Helsingborg (Table 2). Examination for C. 
difficile was not performed in those reports, and thus its involvement cannot be 
excluded, especially in the two latter cases, where all diseased horses were being 
administered antibiotics immediately prior to onset of colitis. Similar to 
Salmonella,  C. difficile must be regarded as a contagious infection, and 
precautions taken to minimize spread of infection by isolation of all suspected 
cases. The results from study I also emphasize the need for routine examination of 
C. difficile and its toxins in horses with diarrhea, especially in combination with 
antibiotic treatment.  
 
In assessing the role of C. difficile in AAD, a problem is interpretation of the 
presence of C. difficile without detection of toxin in the faeces. C. difficile was 
demonstrated by both culture and cytotoxin test in 4 horses, by culture in 4 horses 
and by cytotoxin test only in 2 horses (study I). In human patients with AAD, 
approximately 75-80% of C. difficile strains are toxin producing (Wilkins & 
Lyerly, 2003). Thus, both history and clinical signs have to be considered before a 
positive culture can be regarded as diagnostic. In study II, one horse proved 
positive on culture whereas cytotoxin was first detected 2 days later, followed by 
positive cultures and/or cytotoxin assays on different days. A reason for this could 
be that equine faeces are nonhomogeneous such that neither organism nor toxin 
may be present on a single occasion. Furthermore, Perrin et al. (1993) also 
reported delayed detection of both the organism and its cytotoxin. This emphasises 
that multiple samples should be taken on several consecutive days.  
 
In nearly all cases of CdAD, some degree of disruption of the colonic microflora 
is required as a predisposing event to overgrowth of a toxigenic C. difficile strain. 
The susceptibility of C. difficile for different antibiotics is of importance, but 
perhaps more critical is the susceptibility of the CR flora, which consists of 
obligately anaerobic bacteria (van der Waaij et al., 1977; Fekety et al., 1979; 
Vollaard & Clasener, 1994). Fekety et al. (1979) observed that the disease could 
both be prevented and induced in the hamster with antibiotics to which the 
etiologic organisms were susceptible. A possible explanation for this dichotomy is 
that a susceptible C. difficile strain may be suppressed during antibiotic treatment, 
but after cessation of treatment when the antibiotic concentration subsides, C. 
difficile regains scope to grow before recovery of CR.  
 
The precise role of antibiotic treatment in the development of acute colitis is 
difficult to evaluate. In a recent study Thomas et al. 2003) reviewed published 
studies of AAD in humans and found that only 2 of 48 had evidence of the causal 
role of the antibiotic. However, the majority of the studies found an association 
between antibiotic treatment and development of diarrhea. As it is difficult to 
demonstrate valid evidence for cause in a majority of cases, ‘association’ is often a 
more correct word to use instead of ‘cause’ or ‘induction’. Nonetheless, in study II 
it was concluded that erythromycin induced severe colitis. It is known that 
different antibiotics have varying effect on the intestinal microflora. As shown in 
Table 3, a variety of key factors for the most common and/or incriminated 
antibiotics are listed together with an estimate of the potential risk for disturbance 
of the intestinal microflora.  
  
Table 3. Various antibiotics and presumed risk for disturbance of  the intestinal microflora of horses
1 
 
Class of antibiotics  Route of 
administration 
Biliary 
excretion 
Absorption with 
p.o. administration 
Activity on anaerobic 
bacteria 
C. difficile 
susceptibility (isolates 
from horses) 
Potential for 
disturbance of the 
intestinal microflora 
Penicillins: 
(penicillin, 
ampicillin) 
 
i.v. / i.m.  
i.v. / i.m. / p.o. 
 
none 
none 
 
- 
moderate 
 
moderate 
moderate 
 
varying 
varying 
 
low 
moderate 
Cephalosporins 
(ceftiofur) 
 
i.v. / i.m. 
 
partly 
 
- 
 
moderate 
 
resistant 
 
moderate 
Bacitracin  not approved for use 
in horses (p.o.) 
none           
         
           
     
poor Gram-pos.
moderate 
resistant moderate?
Glycopeptides 
(vancomycin) 
not approved for use 
in horses (i.v./ p.o.) 
 
 
none 
 
poor 
Gram-pos  
high 
 
sensitive 
 
moderate? 
Metronidazole p.o. yes  good high sensitive low
Trimethoprim/ sulfonamides  i.v. / p.o.   partly  good  moderate  varying  low 
Aminoglycosides 
(gentamicin, amikacin,) 
 
i.v. / i.m. 
 
none 
 
- 
 
none 
 
resistant 
 
low 
Macrolides 
(erythromycin) 
 
p.o. / i.v. 
 
yes 
 
incomplete 
 
high 
 
varying 
 
high 
Lincosamides 
(lincomycin, clindamycin) 
not approved for use 
in horses 
 
yes 
 
good 
 
high 
 
varying 
 
high 
Tetracyclines 
(oxytetracycline) 
 
i.v. 
 
partly 
 
- 
 
high 
 
varying 
 
high 
Rifampicin p.o. partly  good moderate varying moderate
Fluoroquinolones 
(enrofloxacin, ciprofloxacin) 
not approved for use 
in horses (i.v. / p.o.) 
partly  good (enro-)  
poor (cipro-) 
low NT low
 
1 Adapted from: Brumbaugh, 1987; Prescott & Baggot, 1993; Hardman et al., 1996; Beard, 1998; Weese, Staempfli & Prescott, 2001; Sullivan, Edlund & 
Nord, 2001, Båverud, 2002; Båverud et al., 2003; Papich, 2003. NT=not tested 
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Erythromycin/Rifampicin – impact on the equine intestinal 
microflora (Paper II) 
The key findings from the second study were that very low dosages of oral 
erythromycin given to four horses caused marked changes of the faecal flora and, 
in two of these cases induced severe acute colitis. C. difficile and/or its cytotoxin B 
were detected from faecal samples from one of the horses with colitis on various 
days from day 2-10 post initiation of antibiotic treatment. For the second horse 
that developed acute colitis, the only findings in the faecal samples were elevated 
counts of coliform bacteria, a finding observed in all horses given erythromycin. 
In another horse given a 10 fold lower dose, C. difficile and/or its cytotoxin B 
were detected on days 2-5 post-initiation of drug administration. The horse 
exhibited signs of uneasiness and anorexia on days 2 and 3. In the fourth horse, C. 
perfringens was isolated in high numbers (2 x 105/g faeces) for several 
consecutive days. That horse had loose, foul smelling faeces days 5 and 6 post 
antibiotic administration. The dose of erythromycin given in this study was 20-200 
times lower than the recommended dose, 25 mg/kg (Prescott, Hoover & Dohoo, 
1983). The maximum levels of faecal erythromycin concentration measured for 
the horse given the lowest dose was 1.3 µg/g faeces, which is a concentration still 
sufficient to inhibit the growth of many Gram-positive and anaerobic bacteria 
(Wideman & Atkinson, 1991).  
 
Even though the number of horses used in the experiment was limited due to 
ethical considerations, the findings clearly showed that erythromycin has strong 
potential to disturb the equine intestinal microflora, and that even a very low oral 
dose can induce acute colitis. This strongly supports the hypothesis that accidental 
ingestion of minute amounts of erythromycin by mares was sufficient to induce 
the fatal colitis affecting mares with foals being treated with oral erythromycin. 
Furthermore, C. difficile or its cytotoxin was identified in faecal samples from 5 of 
11 mares that developed acute colitis following suspected accidental antibiotic 
intake from their foals, which were being treated for R. equi infections with 
erythromycin and rifampicin (Båverud et al., 1998). Although none of the mares 
tested had faecal concentrations of erythromycin above the detection limit in the 
assay (1.5 µg/g faeces), as discussed above, lower concentrations can cause 
disturbances. The hypothesis of an accidental intake was further supported with 
the findings that foals of diseased mares had consistently higher faecal 
concentrations of erythromycin (88.8-1651.0 µg/g faeces), compared with foals of 
healthy mares (3.7-26.3 µg/g faeces). Similarly, other cases with acute colitis after 
accidental intake of very low oral doses of lincomycin and tetracycline have also 
been described (Raisbeck, Holt & Osweiler, 1981; Keir, Staempfli & Crawford, 
1999).  
 
In Sweden, the oral erythromycin formulation ethylsuccinate is most commonly 
used for treatment of R. equi pneumonia in foals. Erythromycin-base enterotablets 
have also been used with the same severe side effects affecting the mares. In other 
countries the estolate formulation dominates. Both ethylsuccinate and estolate are 
esterified compounds, absorbed well as inactive esters from the duodenum and 
then undergo subsequent hydrolysis to the active free base. Erythromycin base is 
rapidly inactivated in the gastric acid environment if not chemically modified to   40
salts or esters, or made to enterotablets. The latter contains the erythromycin base 
in acid resistant coated corns and erythromycin base will first be liberated in the 
duodenum. At the time of publication of this study (1997), the referees suggested 
that the problem with mares developing acute colitis while their foals were being 
treated with erythromycin and rifampicin was limited to Sweden. Earlier 
pharmacokinetic studies on erythromycin including the ethylsuccinate with 
therapeutic doses to adult horses did not report any gastrointestinal side effects 
(Prescott, Hoover & Dohoo, 1983; Ewing et al., 1994). However, reports of these 
problems with mares have been published from other countries (Wilson, 1992; 
Cohen & Woods, 1999), as well as acknowledged, yet unpublished by foreign 
colleagues. The specific formulation used in Sweden (ethylsuccinate or 
enterotablets) was suggested as a possible factor, but according to the discussion 
above the effect of ethylsuccinate and estolate should be rather similar. A related 
hypothesis was that use of enterotablets is associated with a higher risk as the 
active substance is released in the gut lumen of duodenum and thereby a higher 
intestinal concentration could possibly be achieved. In the study by Båverud et al. 
(1998) 7 of 11 mares with colitis had foals treated with enterotablets and 4 with 
ethylsuccinate. Further, at Skara Animal Hospital, enterotablets were used earlier 
for R. equi treatment of foals, and their dams dominate the colitis cases reported 
from Skara (Table 2).  
 
The fact that the problem with the mares at least appears to be of a more severe 
character in Sweden could rather be due to differences in the intestinal microflora, 
in particular presence or absence of potential pathogens and their antibiotic 
resistance patterns. The C. difficile strains isolated from the two horses were 
resistant to both erythromycin (minimum inhibitory concentration (MIC): >256 
µg/ml) and rifampicin (MIC: >32 µg/ml). Recently, a German group (Baums et al., 
2003) repeated study II by giving the same oral dose of erythromycin to four 
experimental horses. Following this they recovered a nontoxigenic, erythromycin 
resistant  C. difficile strain. Evidently, low doses of erythromycin can promote 
colonization and select for erythromycin-resistant strains of C. difficile. 
Interestingly, in the study of Baums et al. (2003) all horses remained healthy, 
leading to suggestion that colonisation of the intestine with nontoxigenic C. 
difficile can lead to protection against a toxigenic C. difficile-associated 
enterocolitis. This is supported by Sambol et al. (2002) who found that intestinal 
colonisation by nontoxigenic C. difficile strains was highly effective in preventing 
CdAD in hamsters challenged with toxigenic strains, both after early and late 
challenge. In humans, prior asymptomatic colonization with either toxigenic or 
nontoxigenic C. difficile strains reduces the risk of subsequent CdAD (Shim et al., 
1998). Therefore, future use of nontoxigenic C. difficile strains as probiotics might 
be an option for prevention of CdAD.  
 
Another early hypothesis was that rifampicin and erythomycin potentiated each 
other’s effect on the microflora, but the present study proved that solely 
erythromycin was able to disturb the microflora enough to induce severe acute 
colitis. Further, the three horses given only rifampicin remained normal in all 
aspects and there were no abnormal changes in the parameters examined on faecal 
samples. The concentrations measured of rifampicin in faecal samples were 0.6-
0.7 µg/g faeces. Rifampicin should have some potential to disturb the intestinal   41 
microflora; the drug is given orally, undergoes biliary excretion and has moderate 
activity against anaerobes. However, it is rapidly absorbed and adverse effects of 
oral rifampicin are rarely reported (Beard, 1998). There are no reports describing 
rifampicin alone in association with AAD in horses, and it has been used safely at 
the University clinic, Uppsala, in adult horses in much higher doses without any 
reported side effects. Furthermore, rifampicin has not been described implicated in 
enterocolitis in humans (Fekety et al., 1979). It appears therefore that, despite its 
antibacterial spectrum and pharmacokinetic properties the risk of acquiring 
diarrhea after use of rifampicin is low. 
 
Penicillin – impact on the intestinal microflora (Paper I, IV) 
All horses positive for C. difficile in study I had been treated with β-lactam 
antibiotics, either solely (19 cases) or in combination with other antibiotics (Table 
4). This is in accordance with McGorum, Dixon & Smith (1998) who found that 
14 of 15 cases of AAD were treated with penicillin, of which 10 were given 
penicillin only. Weese (2000) reported that in cases of AAD, 17 of 40 were treated 
with penicillin, alone or in combination. As in human medicine (Aronsson, Möllby 
& Nord, 1982), the reason why penicillin is the antibiotic most commonly 
associated with acute colitis, at least in Sweden, is probably that it is by far the 
antibiotic most frequently used in horses. Intuitively, after parenteral 
administration the penicillin concentration in the large intestinal contents should 
be low. However, after a dose of 10 mg/kg of Penicillin G sodium i.v., caecal 
concentration of penicillin G of 0.6 µg/ml was measured, which should be enough 
to substantially affect the sensitive anaerobic flora (Horsepool & McKellar, 1995). 
Further, the growth of C. difficile would probably be preferentially favoured by 
this concentration since most strains of C. difficile have an MIC for penicillin of 1 
µg/ml or more (Båverud et al., 2003).  
 
 
Table 4. Antibiotics used in 25 horses developing acute colitis (Paper I) 
 
No. of cases   Antibiotics 
8 procaine  benzylpenicillin 
7 potassium  benzylpenicillin 
4 sodium  ampicillin 
2  procaine benzylpenicillin + dihydrostreptomycin sulphate 
2  potassium benzylpenicillin + TMP/SDZ 
1  procaine benzylpenicillin + metronidazole 
1  sodium ampicillin + metronidazole 
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Experimental infection with C. difficile (Paper IV) 
After experimental oral infection, C. difficile was excreted in the faecal samples on 
significantly more sampling occasions when the horses were pre-treated with 
penicillin (p=0.04). This supports clinical experience that penicillin is the 
antibiotic most often incriminated in AAD in horses (Study I; Weese, 2000; 
McGorum, Dixon & Smith, 1998).  
 
Neither C. difficile toxins A nor B were found in any of the samples throughout 
the study and none of the horses developed diarrhea. Possibly, the numbers of C. 
difficile  in the large intestine of these horses were insufficient to produce 
detectable amounts of toxin. A correlation between the number of toxin-producing 
C. difficile present in the large intestine and the detection of toxin has been 
described (Greiß et al., 1996). Besides disruption of the protective flora and 
overgrowth of toxigenic strains, there are probably additional factors even more 
refractory to evaluation that may contribute to induction of colitis, such as other 
ongoing diseases and stress from hospitalisation or transportation. Therefore, the 
fact that colitis was not induced by the experimental challenge in the present study 
does not rule out the significance of C. difficile in AAD. 
 
Experimental induction of clostridial enterocolitis has been difficult to 
accomplish in horses. Jones, Shideler & Cockerell (1988b) performed an 
experimental infection with C. difficile to newborn foals and managed to 
reproduce clinical disease in a small proportion of inoculated foals. Both the 
fragile immune system of newborns and the lack of an established intestinal 
bacterial flora make a comparison with adult horses difficult. Acute colitis in adult 
horses has not been experimentally induced with clostridia alone. An alteration of 
the intestinal microflora is also required (Traub-Dargatz & Jones, 1993). There are 
interesting parallels in laboratory animals. Experimental inoculation with C. 
difficile resulted in fatal entero-typhlitis in hamsters pre-treated with vancomycin, 
whereas animals not pre-treated with this antibiotic remained unaffected (Larsson, 
1980). Thus, if an antibiotic, likely to severely disturb the intestinal flora and 
induce colitis, is used together with experimental challenge with clostridia, it is 
difficult to evaluate the effect exerted by the inoculated bacteria. Penicillin is not 
known to disrupt the microflora to the same degree as some other antibiotics, such 
as lincosamides, macrolides or tetracyclines. Moreover, since penicillin is the most 
commonly used antibiotic in horses and also the antibiotic mostly associated with 
AAD, the aim was primarily to study the impact of penicillin on proliferation and 
establishment of C. difficile in the horse intestine after experimental oral infection 
with C. difficile.  
 
Salmonella 
Paper IV, as accepted for publication, was focused entirely on C. difficile. 
However, the faecal samples were also examined for C. perfringens and 
Salmonella. Notably, two horses shed Salmonella Typhimurium phage type 40 
following penicillin treatment and inoculation with C. difficile (Study B), horse # 7 
on day 3 and horse #8 on days 3, 4, 5, and 8 post-inoculation with C. difficile.   43 
These two horses developed adverse clinical signs with fever and depression but 
no signs of diarrhea. The blood values from horse # 8 showed leucopenia with 
toxic changes and a left shift on day 3-5. Both horses were euthanised on day 22 
post inoculation and there were no related pathological changes on necropsy and 
culture from lymph nodes, intestinal mucosa, liver and spleen failed to 
demonstrate Salmonella spp. 
 
Even though Salmonella is rarely isolated in horses in Sweden, the type 
recovered here is the one most commonly found (Eld et al., 1991; Malmqvist et 
al., 1995). The two horses positive for Salmonella had 14 negative faecal cultures 
prior to shedding Salmonella. It is, however, possible that Salmonella were 
already present in low numbers as part of the residential flora, yet not recoverable 
on our pre-experimental faecal cultures. This possibility is supported by an earlier 
study in which two ponies treated with lincomycin subsequently shed Salmonella 
despite 8 negative faecal cultures prior to the onset of the experiment (Staempfli et 
al.,  1992a). In another study performed on 9 mares eventually shown to be 
infected and shedding Salmonella at or around foaling, only 2.3% (2/87) of pre-
foaling cultures were positive (Walker et al., 1991). It is well known that 
asymptomatic carriers of Salmonella exist (McCain and Powell, 1990; Traub-
Dargatz, Salman & Jones, 1990), only shedding under certain circumstances, for 
instance when the individual is stressed or due to antibiotic treatment (Hird, 
Pappaioanou & Smith, 1984; Owen, Fullerton & Barnum, 1983) The disturbance 
of the intestinal microflora due to the inoculation of C. difficile, in combination 
with penicillin pre-treatment, possibly created a favourable environment in the 
intestine for enhanced growth of Salmonella. 
 
C. perfringens 
C. perfringens was isolated at eight sampling occasions, from two C. difficile 
inoculated horses (4 occasions) and from two controls (4 occasions). Four samples 
were from penicillin treated horses (study B) and four were from non-treated 
horses (study A). The fact that C. perfringens was found at the same frequency in 
faecal samples from C. difficile inoculated horses, with or without previous 
penicillin treatment, compared to controls suggests that, at least in the present 
model, the biology of this organism was not greatly altered. The results further 
suggest that penicillin treatment of horses is not a major risk factor for causing 
intestinal disturbances due to overgrowth of C. perfringens. Furthermore, in study 
I, C. perfringens was not implicated as a potential causative agent in AAD, but 
isolated from 4 of 22 horses with colitis unrelated to antibiotic treatment.  
 
However, a varying isolation frequency of C. perfringens in association with 
colitis in different places and periods has been reported (Andersson et al., 1971; 
Wierup, 1977; Wierup & DiPietro, 1981; Donaldsson & Palmer, 1999; Herholz et 
al., 1999; Weese, 2000; Weese, Staempfli & Prescott, 2001). The reason for this 
remains unknown, but one theory proposed is that differences in feeding play a 
considerable role, as suggested by Wierup and DiPietro (1981) concerning 
prevalence in healthy horses. Furthermore, Wierup (1977) reported increased 
faecal counts of C. perfringens in the absence of signs of disease in a group of 
trotters in training (22/42 horses) given dietary supplement containing lysine and   44
methionine. Wierup & DiPietro (1981) also emphasized that a diagnosis cannot be 
based only on high C. perfringens counts, even if there is a clear association with 
high counts and disease. Leakage of plasma proteins into the lumen of the intestine 
during colitis can favour the growth of C. perfringens (Palmer, 1992a). Further, 
this author suggests that the significance of recovering C. perfringens may be 
more as a marker of massive protein leakage and a disrupted microflora rather 
than being a cause, an opinion shared by Nielsen & Vibe-Petersen (1979) and 
Larsen (1997). The latter author reported findings of C. perfingens from very few 
cases of colitis during 1987-1997 at the Norwegian College of Veterinary 
Medicine.  
 
With regard to prevalence of C. perfringens toxins, variable results have been 
reported. Studies by Herholz et al. (1999), showed a high frequency (52%) of β2-
toxigenic C. perfringens strains in horses with typhlocolitis, and reported that the 
majority of horses were treated with antibiotics and had a high mortality. The 
authors suggested that β2-toxigenic C. perfringens might be particularly fatal in 
combination with antibiotic treatment. Further, these authors isolated both 
toxigenic and nontoxigenic C. difficile as well as C. perfringens type A to a lesser 
degree, but no C. perfringens strains contained the gene for enterotoxin. In other 
studies CPE was detected in samples from 16 and 19% (9/57 and 9/47 
respectively) of diarrheic adults but was absent in horses without gastrointestinal 
disease (57 and 47 respectively) (Donaldson & Palmer, 1999; Weese, Staempfli & 
Prescott, 2001). The latter author found no association between spore count and 
CPE.  
 
Toxin assays for C. perfringens were not performed in the present studies. It 
appears that the role of C. perfringens as a pathogen in colitis in adult horses is 
even less clear than is the role of C. difficile. However, when consolidating earlier 
knowledge and recent reports it still appears that C. perfringens is of importance in 
the pathogenesis of colitis, but further investigations should be performed to 
understand more fully the role of both these organisms, including detection of 
toxins and toxigenicity of isolated strains. 
 
Isolation of more than one pathogen 
In the present study it was presumed that adverse clinical signs in horse # 7 and #8 
originated from the Salmonella infection and not from inoculated C. difficile, as no 
toxins could be detected. However, simultaneous isolation of more than one 
pathogen from the same diseased horse are commonly reported (Wierup, 1977; 
Beier, Amtsberg & Peters, 1994; Cosmetatos et al., 1994; Madewell et al., 1995; 
Greiß et al., 1996; Madigan et al., 1997; Herholtz et al., 1999), and there are 
reports of both C. difficile and C. perfringens toxin detection from faecal samples 
of the same horse (Donaldson & Palmer, 1999; Weese, Staempfli & Prescott, 
2001). The cause and effect in these cases are impossible to evaluate. For example, 
in the outbreak of C. difficile-associated diarrhea described by Madewell et al., 
(1995),  Salmonella  Krefeld was also isolated from one horse, and it was 
considered to be infected simultaneously with the two pathogens. On the other 
hand, Wierup (1977) suggested that the isolation of Salmonella together with C. 
perfringens in the intestinal content of one horse might be regarded as a secondary   45 
finding. Further studies are clearly needed to better clarify the roles of different 
Clostridium spp. and Salmonella in acute colitis and AAD. 
 
Trimethoprim/Sulfonamides – impact on the intestinal 
microflora (Paper III) 
With given doses of TMP/SDZ the horses seemed unaffected and the faecal 
consistency appeared normal during the whole study. No major changes in the 
intestinal microflora were observed, which suggests a low risk of this drug 
combination concerning gastrointestinal disturbances, an opinion shared by White 
and Prior (1982). Furthermore, Wilson et al. (1996) showed that diarrhea was not 
associated with trimethoprim/sulphonamide treatment either in an extensive case 
control study or in a cohort study. In the present study, neither C. difficile, C. 
perfringens nor Salmonella were found in faecal samples following the i.v. and 
oral TMP/SDZ treatment. An initial approximate 10-fold reduction of the number 
of coliform bacteria was notable with no apparent difference between i.v. and oral 
administration. After completing the treatment, the numbers returned to normal. 
This was also the only change noted by White & Prior (1982) after TMP/SDZ 
administration.  
 
It appears that reduction of counts of coliform bacteria does not reflect a 
severely disrupted intestinal microflora. In contrast, rapid increases in counts of 
coliform bacteria were noted after both erythromycin and rifampicin 
administration (study II). This has also been seen after oral administration of 
oxytetracycline (Andersson et al., 1971; White & Prior, 1982), clindamycin 
together with lincomycin (Prescott et al., 1988), and amikacin (Horspool, Taylor 
& McKellar, 1994), as well as in several horses with AAD in study I (not shown 
in the paper). Wierup (1977) did not state an upper limit of counts of coliform 
bacteria, but the present results suggest that an increase would better reflect a 
disruption of the flora than a decrease. This is in agreement with Voollard and 
Clasener (1994) who proposed that impairment of the CR flora in humans is 
indicated by an increase in the concentration of coliform bacteria. Furthermore, 
this increase may result in more endotoxin production and impairment of the 
mucosal barrier against endotoxin absorption (Jones, 2000).  
 
Oral adminstration 
Orally administered antibiotics that are well absorbed in the upper part of the small 
intestine, as the studied combination of TMP/SDZ studied, generally have minor 
impact on the large intestine microflora, whereas antibiotics that are poorly or 
incompletely absorbed can cause significant changes (Nord, 1993). It is reasonable 
to assume that the risk for disturbance of the microflora is generally increased with 
antibiotics used for oral treatment because higher concentrations of the drug in the 
large intestinal content normally should be achieved. However, this was not the 
experience in study I, where most of the cases reported with AAD occurred after 
parenteral use, a result also found by Weese, (2000). Certainly, the parenteral 
route is more commonly used in horses, with the exception of oral preparations of 
trimethoprim/sulfonamides.   46
 
Also of importance with oral administration is that time of feeding in relation to 
antibiotic administration affects the systemic availability of the drug, shown for 
some drugs to be lower with feeding before antibiotic administration compared to 
feeding after administration (Baggot, 1992; Bogan et al., 1984). Physical or 
chemical binding of the drug to the ingesta probably causes this (van Duijkeren et 
al., 1995a; 1995b; McKellar & Horspool, 1995). If oral antibiotics were given in 
connection with or just after feeding, a consequence of this binding could be 
subsequent release of the drug into the large intestine after fermentative digestion 
of the feedstuff and higher intestinal antibiotic concentrations.  
 
In the present study the horses were not fasted and t1/2β were greater than in 
studies with the horses fasted prior to drug administration (van Duijkeren et al., 
1994). Thus, it seems that the most appropriate time to administer the drug is 
before feeding. Ensink et al. (1996) found that previous lack of appetite was 
significantly correlated with a high incidence of diarrhea in horses receiving 
TMP/SDZ. All horses in the present study had normal appetite. In accordance with 
the above discussion great variation in plasma concentrations between individual 
horses were observed in study III. Others have also described this after oral 
administration of varying trimethoprim/sulphonamide combinations (Sigel et al., 
1981; Morgan & White, 1983; Bogan et al., 1984; van Duijkeren et al., 1994; 
1995a; 1995b). Further reasons for these variations could be individual differences 
in gastric emptying and to some extent, bile excretion with recirculation of the 
drugs or metabolism in the intestinal mucosa or the liver before reaching the 
systemic circulation (Baggot, 1992). 
 
Clinical outcome and treatment of colitis (Paper II) 
Diseased horses in the present study developed the dramatic and severe clinical 
changes on the third day of antibiotic treatment. Day three was also the mean 
debut day of diarrhea among the 25 horses in study I. The time after initiation of 
antibiotic treatment until onset of disease is typically reported to be only a few 
days (Andersson et al., 1971; Cook, 1973; Prescott et al., 1988; Staempfli, 
Prescott & Brash, 1992; Staempfli et al., 1992; Ensink et al., 1996). This shows 
that the disturbance of the intestinal microflora takes place in the first days of 
treatment, and that the risk for diarrhea thereafter is independent of duration of 
therapy. In humans, the median time for occurrence of symptoms is described to 
be longer, averaging 9 days after the start of treatment (Wiström et al., 2001). 
However, time of onset of disease can also be longer in horses, and even extend to 
beyond cessation of antibiotic administration (Magdesian et al., 1997; Weese, 
2000).  
 
One of the two diseased horses in study II was treated successfully with oral 
bacitracin, together with large amounts of i.v. fluids and flunixin meglumine and 
recovered within two days. Despite similar treatment, the clinical condition of the 
other horse gradually deteriorated with marked dehydration and typical signs of 
toxaemia. After 24 h, with decreased intestinal sounds and increased signs of 
colic, it was subjected to euthanasia for ethical reasons. Bacitracin treatment was 
initially presumed to have contributed to the rapid recovery in the first horse, but   47 
paradoxically the C. difficile strain isolated from that case was resistant to 
bacitracin (MIC>256 µg/ml), as also reported by others (Jang et al., 1997; Weese, 
Staempfli & Prescott, 2001; Båverud et al., 2003). Mild CdAD may resolve when 
the offending antibiotic treatment is discontinued and the normal microflora is re-
established. In severe cases where antibiotic treatment can be considered, 
metronidazole should be the first choice before vancomycin, due to concerns 
about spread of vancomycin-resistant bacteria and lower cost. Furthermore, two 
horses in study I acquired AAD despite inclusion of metronidazole in the previous 
treatment. This is in accordance with reports in human medicine. Neither 
metronidazole nor vancomycin were effective as prophylaxis of AAD when 
included in therapy (Wiström et al., 2001). 
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Concluding remarks 
 
The knowledge of how different antibiotics influence the intestinal microflora in 
horses is still limited. The work described in this thesis shows that C. difficile is 
associated with acute colitis in adult horses, following treatment with antibiotics. 
Most of the horses positive for C. difficile were treated with β-lactam antibiotics, 
alone or in combination with other antibiotics. Penicillin treatment predisposes the 
establishment of C. difficile in the horse intestine. Further it was demonstrated that 
very low oral doses of erythromycin could induce acute colitis associated with 
major changes of the intestinal microflora. Thus, it was considered most likely that 
the fatal colitis affecting the mares was due to accidental ingestion of 
erythromycin. In contrast, very low oral doses of rifampicin and therapeutic doses 
of both oral and i.v. TMP/SDZ were not associated with major changes in the 
intestinal flora and no evidence of gastrointestinal disturbances was observed. 
 
Nevertheless, broad generalisations regarding the safety of any particular 
antibiotic used in equine practice should be avoided unless there are sufficient data 
to fully assess the risk. Our own choice of antibiotics in attempting to minimise 
risk of antibiotic associated diarrhea may not be the same as in other regions of the 
world, and clearly defined antibiotic usage guidelines in regard to risk of induction 
of diarrhoea in the horse, even if available, cannot be applied globally. This is 
likely because the intestinal flora varies with type of feeding the horse is given, 
and on the variable management and hygiene situation in different regions of the 
world. It appears that every time a horse is treated with antibiotics there is 
invariably a relative risk of colitis that has to be considered, and thus there are no 
completely safe antibiotics. As clinicians it is our responsibility to avoid 
unnecessary antibiotic treatment in the horse. Further, potential pre-disposing risk 
factors for inducing acute colitis, for example; stress, starvation, withholding 
roughage, abdominal surgery, intestinal stasis, hospitalisation, long transportation, 
presence of other disease/s and concurrent medications need to be carefully 
considered in each case when choosing to administer antibiotics. Ideally, 
antibiotics should be administered only when there is a known or highly suspected 
bacterial infection or when antibiotic prophylaxis is required. If there is a need for 
antibiotic treatment there should be a high likelihood of a successful therapeutic 
outcome. Antibiotics known to be associated with a high risk for development of 
colitis such as macrolides and lincosamides should be avoided. Furthermore, use 
of antibiotics that are poorly evaluated with regard to safety and effectiveness in 
horses clearly deviates from sound medical management principles.  
 
Finally, as most clinicians are aware, there is an ever-increasing problem world-
wide with development and spread of antibiotic-resistant bacteria, such as multi-
resistant  Salmonellae and C. difficile. Indiscriminate use of antibiotics only 
increases the potential for emergence and spread of these resistant bacteria that 
pose an increasing threat to both human and animal health. 
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